EXHIBIT 99.1
ITEM 6.SELECTED FINANCIAL DATA
FIVE-YEAR FINANCIAL STATISTICS
DIMON Incorporated and Subsidiaries
| | | | | | | | | | | | | | | | | | | | |
(in thousands, except per share amounts and number of stockholders)
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
| | 2003
| | | 2002
| | | 2001
| | | 2000
| |
Summary of Operations | | | | | | | | | | | | | | | | | | | | |
| | | | | |
Sales and other operating revenues | | $ | 802,083 | | | $ | 1,197,467 | | | $ | 1,192,613 | | | $ | 1,343,743 | | | $ | 1,412,887 | |
Restructuring and asset impairment charges (recovery) | | | 22,539 | | | | — | | | | — | | | | (5,307 | ) | | | (211 | ) |
Income (loss) from continuing operations | | | (21,539 | ) | | | 26,829 | | | | 26,258 | | | | 24,267 | | | | 16,452 | |
Income (loss) from discontinued operations | | | (11,329 | ) | | | (549 | ) | | | 1,218 | | | | 730 | | | | 1,536 | |
Cumulative effect of accounting changes, net of income taxes | | | — | | | | — | | | | — | | | | (103 | ) | | | — | |
Extraordinary item – Iraqi receivable recovery, net of income taxes | | | | | | | 1,777 | | | | | | | | | | | | | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Net Income (Loss) | | $ | (32,868 | ) | | $ | 28,057 | | | $ | 27,476 | | | $ | 24,894 | | | $ | 17,988 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Per Share Statistics | | | | | | | | | | | | | | | | | | | | |
Basic Earnings (Loss) Per Share: | | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations | | $ | (.48 | ) | | $ | .60 | | | $ | .59 | | | $ | .55 | | | $ | .37 | |
Income (loss) from discontinued operations | | | (.25 | ) | | | (.01 | ) | | | .03 | | | | .02 | | | | .03 | |
Net income (loss) | | | (.73 | ) | | | 63 | | | | .62 | | | | .56 | | | | .40 | |
Diluted Earnings (Loss) Per Share: | | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations | | $ | (.48 | ) | | $ | .59 | | | $ | .58 | | | $ | .54 | | | $ | .37 | |
Income (loss) from discontinued operations | | | (.25 | ) | | | (.01 | ) | | | .03 | | | | .02 | | | | .03 | |
Net income (loss) | | | (.73 | )* | | | .62 | * | | | .61 | * | | | .56 | * | | | .40 | * |
Dividends paid | | | .225 | | | | .275 | | | | .20 | | | | .20 | | | | .20 | |
Book value | | | 9.19 | | | | 10.16 | | | | 9.74 | | | | 9.23 | | | | 9.06 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Balance Sheet Data | | | | | | | | | | | | | | | | | | | | |
Working capital (1) | | $ | 419,703 | | | $ | 443,790 | | | $ | 436,012 | | | $ | 179,238 | | | $ | 441,055 | |
Total assets | | | 1,357,404 | | | | 1,353,152 | | | | 1,277,090 | | | | 1,182,089 | | | | 1,266,749 | |
Revolving Credit Notes and Other Long-Term Debt (1) | | | 347,681 | | | | 351,569 | | | | 328,883 | | | | 128,641 | | | | 400,856 | |
Convertible Subordinated Debentures | | | 73,328 | | | | 73,328 | | | | 73,328 | | | | 73,328 | | | | 73,328 | |
Stockholders’ equity | | | 414,885 | | | | 454,573 | | | | 434,663 | | | | 411,539 | | | | 403,504 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Other Data | | | | | | | | | | | | | | | | | | | | |
Ratio of Earnings to Fixed Charges (2) | | | — | | | | 1.70 | | | | 1.72 | | | | 1.59 | | | | 1.41 | |
Common shares outstanding at year end | | | 45,162 | | | | 44,737 | | | | 44,640 | | | | 44,575 | | | | 44,525 | |
Number of stockholders at year end (3) | | | 5,945 | | | | 5,946 | | | | 6,025 | | | | 4,611 | | | | 4,899 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
* | Assumed conversion of Convertible Debentures at the beginning of the period has an antidilutive effect on earnings per share. For the nine months ended March 31, 2004, all outstanding restricted stock and stock options are excluded because their inclusion would have an antidilutive effect on the loss per share. |
(1) | Working capital increased in fiscal 2002 due to the issuance of long-term debt which was used to refinance both the current portion of long-term debt and other short-term debt. See Note G to the “Notes to Consolidated Financial Statements.” |
(2) | In 2004, fixed charges exceeded earnings by approximately $24.4 million. |
(3) | Includes the number of stockholders of record and non-objecting beneficial owners. |
1
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS
Executive Overview
The following executive overview is intended to provide significant highlights of the discussion and analysis that follows.
Operating Results
From the outset of our shortened fiscal year we anticipated that our financial results would be relatively weak due to the ongoing major transition in global sourcing of leaf tobacco. Specifically, we anticipated that fiscal 2004 would be negatively affected by ongoing crop declines in both the United States and Zimbabwe. Due to the shortened year, we were unable to benefit from much larger South American crops which would have substantially offset this negative impact. As the year progressed, that situation was aggravated by weather related declines in prior year crops in both Brazil and Malawi. These global conditions resulted in lower sales and other operating revenues.
Our financial results further suffered from the effect of the profoundly weak U.S. dollar, which inflated our reported selling, administrative and general expenses and depressed gross profits on our largely U.S. dollar denominated global sales.
Restructuring, Asset Impairment Charges and Discontinued Operations
As a consequence of the ongoing transition in global sourcing of leaf tobacco and over-capacity within certain markets of the industry, we initiated a strategic review in the period to adjust our production capacity and organization to better match current requirements. This review resulted in restructuring and asset impairment charges of $29.5 million in fiscal 2004 and the decision on September 30, 2004 to discontinue all Italian operations. The major initiatives are highlighted below followed by further discussion. See Notes B and C to the “Notes to Consolidated Financial Statements.”
| • | United States and European fixed asset impairment charges, primarily machinery and equipment, were $9.9 million and severance and other costs for employees notified were $1.7 million. |
A restructuring plan designed to improve long-term profitability was approved by our Board of Directors. The decision to implement this restructuring plan, especially the closure of our Danville processing facility, has been a difficult one and we regret the dislocation it will inevitably cause our employees. However, we expect that the non-competitive leaf prices for U.S. grown tobacco will continue to diminish the volume of tobacco available to process in this country, and that consolidating our U.S. production into a single facility will enable us to continue to compete effectively while serving our customers. In Europe, the expected reduction or elimination of EU subsidies to tobacco growers will make these markets extremely challenging, and we are exiting those European markets that show insufficient growth and profitability opportunities. As a result of these actions in the United States and Europe, we also expect to incur additional severance charges, estimated at $7 million, in our 2005 fiscal year.
| • | In Zimbabwe, fixed asset impairment charges, relating to land and buildings no longer used in operations, were $4.9 million. |
Although we remain committed to Zimbabwe as a major source of good quality, reasonably priced leaf tobacco, diminished forecasted cash flows related to the continued political and social instability in that country have impaired the value of certain non-production assets there.
| • | Impairment charges related to a non-tobacco investment totaled $6.1 million. |
The results for the third quarter also reflect additional asset impairment charges in connection with an investment in a newly consolidated U.S.-based non-tobacco business. These charges include asset impairment charges of $.7 million and $5.4 million for goodwill impairment.
| • | In Italy, fixed asset impairment charges were $6.9 million relating primarily to machinery and equipment. |
As a result of the Plan, the impairment charge was recorded based on fair values determined by subsequent asset disposal agreements. On September 30, 2004, concurrent with the sale of the Italian processing facility, we made a decision to discontinue all Italian operations as part of our ongoing review. We expect to exit the Italian market completely by September 30, 2005. We have reclassified amounts and balances related to our Italian operations, including the $6.9 million impairment charge, to discontinued operations for the fiscal years ended June 30, 2002 and 2003 and the nine month transition year ended March 31, 2004.
Covenant Compliance
As a consequence of our weak financial results at March 31, 2004, we were again unable to remain in compliance with the consolidated fixed charge coverage ratio covenant in our syndicated bank credit facility. As explained in more detail under “Liquidity and Capital Resources” we obtained a waiver and amendment resetting the required coverage ratio to lower but escalating levels through fiscal year 2005.
2
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS (Continued)
Outlook
We will continue to focus on regions of the world that are growing in market importance in an effort to achieve profitable financial results. We believe that the restructuring plans should position us to better capitalize on anticipated larger crops in South America, and allow us to focus on delivering outstanding customer service, exercise expense discipline and maintain a strong balance sheet over the long term. Although we are optimistic about the longer-term effects of our restructuring plans, it is too early to quantify the benefits that facility consolidation and strategic sourcing will have on our cost structure.
Change in Fiscal Year
On June 23, 2003, our Board of Directors adopted a change in fiscal year end from June 30 to March 31. The primary purpose of the change is to better match the financial reporting cycle with natural global crop cycles for leaf tobacco. Our predecessor companies selected the June 30 fiscal year end many years ago when operations were substantially domestic because it matched the U.S. crop cycle. However, given the importance of our international operations today, particularly those in South America, a March 31 year-end is a more appropriate fiscal end. As a result of this change, we are reporting a nine month transition year ending March 31, 2004. Our new fiscal year 2005 commenced on April 1, 2004. In order to facilitate comparison with the nine month period ended March 31, 2004, we have provided condensed consolidated financial data for the nine month period ended March 31, 2003 (unaudited) in Note A to the “Notes to Consolidated Financial Statements.”
General
DIMON was formed through the April 1, 1995 merger of Dibrell Brothers, Incorporated (established in 1873) and Monk-Austin, Inc. (established in 1907). We believe that we are the world’s second largest independent purchaser and processor of leaf tobacco.
Critical Accounting Policies and Estimates
The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of our financial statements. Actual results may differ from these estimates under different assumptions or conditions.
Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties, and potentially result in materially different results under different assumptions and conditions. Our critical accounting policies have been reviewed with the Audit Committee of the Board of Directors.
Inventories
Inventories are valued at the lower of cost or market. Inventories are reviewed and written down for changes in market value based on assumptions related to future demand and worldwide and local market conditions. If actual demand and market conditions vary from those projected by management, additional write downs to lower of cost or market value may be required. Inventory write downs as of March 31, 2004 and June 30, 2003 were $5.0 million and $3.1 million, respectively.
Income Taxes
We operate in multiple tax jurisdictions both inside and outside the United States. Accordingly, we must estimate current income tax provisions in each of these jurisdictions as well as assess the income tax effects resulting from differing treatment of items for financial reporting and income tax purposes. We are also subject to tax audits in each of these jurisdictions, which could result in changes to estimated income tax expense. Because tax audit adjustments in certain jurisdictions can be significant, we record accruals representing our best estimate of the probable resolution of these matters. In determining the valuation allowances to establish against deferred tax assets, we consider many factors, including the specific taxing jurisdiction, any applicable loss or credit carryforward period, income tax strategies and forecasted earnings for the entities in each jurisdiction. A valuation allowance is recorded if, based on the weight of available evidence, we conclude that it is more likely than not that some portion or all of the deferred tax asset will not be realized. These factors could be subsequently affected by changes in future taxable income and its sources and by changes in U.S. or foreign tax laws. Our effective income tax rate could be impacted by changes in these factors. See Note K to the “Notes to Consolidated Financial Statements” for further disclosure on income taxes.
3
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS (Continued)
Critical Accounting Policies (Continued)
Goodwill and Other Intangible Assets
We test the carrying amount of goodwill annually as of the first day of the last quarter of our fiscal year and whenever events or circumstances indicate that impairment may have occurred. Impairment testing is performed in accordance with SFAS No. 142, “Goodwill and Other Intangible Assets.” Impairment testing is based on a discounted cash flow approach to determine fair value. The determination of fair value requires significant management judgment including estimating future sales volumes, growth rates of selling prices and costs, changes in working capital, investments in property and equipment and the selection of an appropriate discount rate. We also test the sensitivities of these fair value estimates to changes in our earnings growth rate and discount rate.
A one-percentage-point decrease in the earnings growth rate would not indicate possible impairment. At January 1, 2004, the discount rate would need to increase more than 84 basis points before a possible impairment would be indicated. If the carrying amount of the net assets exceeds fair value, a possible impairment would be indicated. If a possible impairment is indicated, we would estimate the implied fair value of goodwill by comparing the carrying amount of the net assets excluding goodwill to the total fair value. If the carrying amount of goodwill exceeds its implied fair value, an impairment charge would be recorded. We also use judgment in assessing whether we need to test more frequently for impairment than annually. Factors such as unexpected adverse economic conditions, competition and other external events may require more frequent assessments. See Notes A and C to the “Notes to Consolidated Financial Statements” for further disclosure of goodwill and impairment.
We have no intangible assets with indefinite useful lives. We have other intangible assets with a gross carrying amount of approximately $18.7 million and a net carrying amount of about $10.5 million. These intangibles are being amortized over their estimated useful lives and are tested for impairment whenever events or circumstances indicate that impairment may have occurred. If the carrying amount of an intangible asset exceeds its fair value based on estimated future undiscounted cash flows, an impairment loss would be indicated. The amount of the impairment loss to be recorded would be based on the excess of the carrying amount of the intangible asset over its discounted future cash flows. We use judgment in assessing whether the carrying amount of our intangible assets is not expected to be recoverable over their estimated remaining useful lives. The factors considered are similar to those outlined in the goodwill impairment discussion above. See Note A to the “Notes to Consolidated Financial Statements.”
Property and Depreciation
Estimating the useful lives of property, plant and equipment requires the exercise of management judgment, and actual lives may differ from these estimates. Changes to these initial useful life estimates are made when appropriate. Property, plant and equipment are tested for impairment in accordance with SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” whenever events or changes in circumstances indicate that the carrying amounts of such long-lived assets may not be recoverable from future cash flows. Impairment testing requires significant management judgment including estimating the future sales volumes, growth rates for selling prices and costs, alternative uses for the assets and estimated proceeds from disposal of the assets. Impairment testing is conducted at the lowest level where cash flows can be measured and are independent of cash flows of other assets. An asset impairment would be indicated if the sum of the expected future cash flows from the use of the asset (undiscounted and without interest charges) is less than the carrying amount of the asset. An impairment loss would be measured based on the difference between the fair value of the asset and its carrying amount. Fair value is the amount at which the asset could be bought or sold in a current transaction between willing parties and may be estimated using a number of techniques, including quoted market prices or valuations by third parties, present value techniques based on estimates of cash flows, or multiples of earnings or revenue performance measures. The fair value of the asset could be different using different estimates and assumptions in these valuation techniques which would increase or decrease the impairment charge.
Under SFAS No. 144, a component of a business is reported as discontinued operations if the operations and cash flows have been reclassified from ongoing operations and there will be no significant involvement in such operations in the future. On September 30, 2004, concurrent with the sale of the Italian processing facility, we decided to discontinue operations in Italy and are reporting those operations as discontinued operations in our financial statements accordingly. See Notes B and C to the “Notes to Consolidated Financial Statements” for further disclosure.
4
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS (Continued)
Critical Accounting Policies (Continued)
Pensions and Postretirement Health Care and Life Insurance Benefits
The valuation of our pension and other postretirement health care and life insurance plans requires the use of assumptions and estimates that are used to develop actuarial valuations of expenses, assets and liabilities. These assumptions include discount rates, investment returns, projected salary increases and benefits and mortality rates. The significant assumptions used in the calculation of pension and postretirement obligations are:
Discount rate: The discount rate is based on returns available on high-quality fixed income obligations, such as those included in the Moody’s Aa bond index.
Salary increase assumption: The salary increase assumption reflects our expectations with respect to long-term salary increases of its workforce. Historical pay increases, expectations for the future, and anticipated inflation and promotion rates are considered in developing this assumption.
Cash Balance Crediting Rate: Interest is credited on cash balance accounts based on the yield on one-year Treasury Constant Maturities plus 1%. The assumed crediting rate thus considers the discount rate, current treasury rates, current inflation rates, and expectations for the future.
Mortality Rates: Mortality rates are based on gender-distinct group annuity mortality (GAM) tables.
Expected return on plan assets: The expected return reflects asset allocations, investment strategy and our historical actual returns.
Termination and Retirement Rates: Termination and retirement rates are based on standard tables reflecting past experience and anticipated future experience under the plan. No early retirement rates are used since benefits provided are actuarially equivalent and there are not early retirement subsidies in the plan.
Management periodically reviews actual demographic experience as it compares to the actuarial assumptions. Changes in assumptions are made if there are significant deviations or if future expectations change significantly. Based upon anticipated changes in assumptions, pension and postretirement expense is expected to increase by $1.6 million in the twelve months ended March 31, 2005 as compared to the nine months ended March 31, 2004. We continually evaluate ways to better manage benefits and control costs. For fiscal 2005, we are considering several alternatives to our postretirement benefits which could significantly reduce our costs. The cash contribution to our cash balance plan in 2004 was $0.9 million and is expected to be $0.6 million in 2005.
The effect of actual results differing from our assumptions are accumulated and amortized over future periods and, therefore, generally affect our recognized expense in such future periods. Changes in other assumptions and future investment returns could potentially have a material impact on our pension and postretirement expenses and related funding requirements.
5
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS (Continued)
Critical Accounting Policies (Continued)
Pensions and Postretirement Health Care and Life Insurance Benefits(Continued)
The effect of a change in certain assumptions is shown below:
| | | | | | | | |
| | Estimated Change in Projected Benefit Obligation Increase (Decrease) (in 000’s)
| | | Estimated Change in Annual Expense Increase (Decrease) (in 000’s)
| |
Change in Assumption (Pension Plans) | | | | | | | | |
1% increase in discount rate | | $ | (6,871 | ) | | $ | (422 | ) |
1% decrease in discount rate | | $ | 7,947 | | | $ | 476 | |
| | |
1% increase in salary increase assumption | | $ | 1,814 | | | $ | 339 | |
1% decrease in salary increase assumption | | $ | (1,568 | ) | | $ | (287 | ) |
| | |
1% increase in cash balance crediting rate | | $ | 849 | | | $ | 93 | |
1% decrease in cash balance crediting rate | | $ | (831 | ) | | $ | (87 | ) |
| | |
1% increase in rate of return on assets | | | | | | $ | (237 | ) |
1% decrease in rate of return on assets | | | | | | $ | 236 | |
| | |
Change in Assumption (Other Postretirement Benefits) | | | | | | | | |
1% increase in health care cost trend rates | | $ | 1,130 | | | $ | 120 | |
1% decrease in health care cost trend rates | | $ | (1,004 | ) | | $ | (104 | ) |
Contingencies
A contingency is an existing condition, situation, or set of circumstances involving uncertainty that will ultimately be resolved when one or more future events occur or fail to occur. Provisions for contingencies are required to be established when it is probable that the future event will or will not occur and that its impact can be reasonably estimated. When we either are not able to make an assessment of an amount or have determined that the probability of a loss occurring is not likely, no liability is recorded in the consolidated financial statements for the contingency. Provisions may be required as circumstances change with respect to ongoing matters or as new issues emerge. See Note O to the “Notes to Consolidated Financial Statements.”
Accounting Matters
In May 2003, FASB issued SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” Under the provisions of SFAS No. 150 certain financial instruments that previously could be accounted for as equity must be presented as liabilities, and assets in some cases, on the balance sheet. We adopted this new standard July 1, 2003 and it did not have a material effect on our financial statements.
In December 2003, the FASB issued a revised Interpretation No. 46, Consolidation of Variable Interest Entities (“FIN 46R”). FIN 46R requires a new approach in determining if a reporting entity consolidates certain legal entities referred to as variable interests entities (“VIEs”), including joint ventures, limited liability companies and equity investments. A VIE is an entity in which the equity investors do not have a controlling interest or have insufficient resources to finance the entity’s activities without receiving additional financial support from the other parties. Under FIN 46R, consolidation of a VIE is required by the investor with the majority of the variable interests in the entity. The revised interpretation delays the effective date to periods ending after December 15, 2003 for special purpose entities and to periods ending after March 15, 2004 for all other types of VIE’s. The adoption of the revised FIN 46R did not have a material effect on our financial position or results of operations.
6
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS (Continued)
Accounting Matters (Continued)
In December 2003, the FASB issued a revision to FASB Statement No. 132 – Employers’ Disclosures about Pensions and Other Postretirement Benefits (“FASB No. 132R”). The revision expands disclosures for defined benefit plans and other postretirement plans in both annual and interim financial statements. The effective date for FASB No. 132R is for fiscal years ending after December 15, 2003. Interim period disclosure is required for interim periods beginning after December 15, 2003. We adopted the additional annual disclosure requirements as of the fiscal year ending March 31, 2004.
Results of Operations
Operating Environment:
Global
We believe that the global supply and demand for leaf tobacco continues to be substantially balanced. However, there are indications that production forecasts, if achieved, could exceed global customer demand. In addition, notable significant tobacco production volume reductions continue in both the United States and Zimbabwe. These reductions, as well as anticipated future reductions in Western Europe, have created a shift in the sourcing of customer requirements primarily to Argentina, Brazil, Asia and certain African countries other than Zimbabwe. This has and will continue to impact the ongoing requirements of our organizational structure and asset base.
Africa
The political and economic situations in Zimbabwe continue to present uncertainties as the country remains in a period of civil unrest accompanied by a deteriorating economy. A further reduction in the Zimbabwe flue-cured crop size from 85 million kilos for the 2003 crop year to approximately 60 million kilos for the 2004 crop year has occurred; however, we are expecting to buy, process and sell quantities similar to that handled in the 2003 crop year. Some customers have shifted portions of their Zimbabwe purchases to Brazil, Argentina and certain other African countries. Flue-cured and burley production in Tanzania, Malawi, Mozambique, the Democratic Republic of Congo and Zambia continues to expand in an effort to retain our customer volumes shifted from Zimbabwe. Utilization of our regional processing facilities continues with tobaccos from Mozambique, Zambia and the Democratic Republic of Congo being packed and exported from our plants in Tanzania, Malawi and Zimbabwe. Customer reactions to our efforts in the African region have been positive and our traditional customer base has remained stable.
South America
We continue to see excellent results in our Brazilian operation as customers shift portions of their Zimbabwe and U.S. requirements to Brazil. Brazil is among our largest source countries in terms of volume and revenue. We consider this region to be a viable area for continued growth in tobacco leaf production and customer commitment. This year Brazil has produced the largest crop recorded in its history, and next year’s crop is predicted to be even larger. However, processing of the current crop has been substantially delayed due to slow delivery of tobacco by farmers. In addition, reduced levels of imports into Brazil have resulted in a shortage of shipping containers and vessels available for tobacco and other exports. These shipping delays could impact the timing of shipments between quarters in fiscal 2005. Argentina has also benefited from the smaller crop size in Zimbabwe and is considered as an additional reliable source to Zimbabwe, Brazil and the United States for flavor tobaccos. The customer base for both Guatemala and Mexico is somewhat limited by the high production costs in those countries. Our operations in those countries generally purchase and process only to customer orders.
Asia
The Asian region provides our customers with a good quality product at a comparatively lower cost. The importance of the Asian region is increasing as our customers expand their cigarette manufacturing operations into the region. In Thailand, we purchase and process tobacco through our own operations. In other areas of Asia, we supervise the purchase and processing of tobacco in conjunction with operations owned by governmental and other third parties. The demand for Asian origin leaf continues to rise and DIMON is expanding its existing operations to accommodate the increasing demand and to participate in this growth.
7
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS (Continued)
Results of Operations(Continued)
Operating Environment:(Continued)
Europe
DIMON remains active in the flue-cured and burley EU markets. The Common Agricultural Policy (CAP) support for tobacco has recently been reformed and will have varying impact on individual EU countries regarding subsidy payments to producers starting in 2006. We are actively addressing the potential effects this will have on our operations in these markets and believe there could be material reductions in production volumes specifically in Western Europe. We believe that Turkey will remain the most important oriental tobacco market. As a result of the introduction of the direct contract buying system, we anticipate crop sizes more in line with demand and a subsequent gradual ending of the large government stocks of the past. Our other “Classical” oriental operations including those in Greece, Bulgaria and Macedonia continue to contribute to the region’s growth, with Macedonia and Bulgaria being markets with a high potential to supply customers needs in the future. To compliment the oriental market, our operations in the “Non-Classical” semi-oriental areas of Kyrgyzstan and Moldova continue to contribute to the total development of the region and serve our customers. We believe DIMON has a strong presence in all the important oriental and semi-oriental markets. On September 30, 2004, concurrent with the sale of the Italian processing facility, we made a decision to discontinue all Italian operations as part of our ongoing plans to realign our operations to more closely reflect worldwide changes in the sourcing of tobacco. We continue to evaluate our European processing operations in order to achieve improved efficiencies and cost reductions.
North America
The production of leaf tobacco in the United States currently operates under a USDA-administered Tobacco Program that restricts supply and induces non-value added costs into the price of farm cured, or “green” tobacco. Increasingly, the relatively high cost of U.S. grown tobacco makes it uncompetitive in the world market. The market for U.S. grown leaf tobaccos has largely become limited to domestic customers, as traditional foreign buyers have significantly reduced or eliminated these tobaccos from their product blends. Based upon diminished U.S. crop production and processing requirements, the Board of Directors approved the fiscal 2005 closing of our Danville-based production facility at the completion of the processing of the 2004 U.S. crop. This resulted in restructuring and asset impairment charges in fiscal 2004 which is discussed further in Note B to the “Notes to Consolidated Financial Statements.” Further severance charges are expected in fiscal 2005. The current U.S. market has substantially converted to direct contract purchasing over the past several years with certain domestic customers now purchasing their requirements directly from farmers. As a result, our U.S. operations are increasingly focused on providing processing services to our customers. There are legislative bills before Congress that could eliminate the Tobacco Program with the potential effect of making U.S. grown leaf tobacco more competitive and stabilizing production in the country. Our Canadian operations continue to contribute to the region’s profitability.
Dark Tobacco
DIMON’s dark air-cured tobacco operations service manufacturers of cigars, dark cigarettes, chewing tobacco, pipe tobacco and roll-your-own. Strong demand continues to exist for quality wrappers and binders for the cigar industry. Demand for both cigar and cigarette dark filler tobaccos remains weak, resulting in continued lower sales volumes from this type of tobacco. Unfavorable weather related growing conditions in Northern Brazil and Indonesia have also resulted in lower quality tobacco crops in these countries.
8
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS (Continued)
Results of Operations(Continued)
Condensed Statement of Consolidated Income
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Nine Months Ended March 31,
| | | Twelve Months Ended June 30,
| |
(in millions) | | 2004
| | | Increase/ (Decrease)
| | | 2003 (unaudited)
| | | 2003
| | | Increase/ (Decrease)
| | | 2002
| |
Sales and other operating revenues | | $ | 802.1 | | | $ | (47.1 | ) | | $ | 849.2 | | | $ | 1,197.5 | | | $ | 4.9 | | | $ | 1,192.6 | |
Gross profit | | | 105.5 | | | | (31.2 | ) | | | 136.7 | | | | 205.3 | | | | 6.9 | | | | 198.4 | |
Selling, administrative and general expenses | | | 88.1 | | | | 11.8 | | | | 76.3 | | | | 113.6 | | | | 5.9 | | | | 107.7 | |
Restructuring and asset impairment charges | | | 22.5 | | | | 22.5 | | | | — | | | | — | | | | — | | | | — | |
Interest expense | | | 32.2 | | | | (2.1 | ) | | | 34.3 | | | | 46.9 | | | | (1.0 | ) | | | 47.9 | |
Interest income | | | 6.4 | | | | 3.9 | | | | 2.5 | | | | 2.9 | | | | (1.0 | ) | | | 3.9 | |
Derivative financial instruments (income)/expense | | | (6.5 | ) | | | (16.9 | ) | | | 10.4 | | | | 12.4 | | | | 2.2 | | | | 10.2 | |
Income taxes (benefit) | | | (0.6 | ) | | | (4.7 | ) | | | 4.1 | | | | 9.1 | | | | (0.8 | ) | | | 9.9 | |
Equity in net income (loss) of investee companies | | | (0.5 | ) | | | (0.3 | ) | | | (0.2 | ) | | | 0.3 | | | | 0.6 | | | | (0.3 | ) |
Minority interests (income) | | | (2.8 | ) | | | (2.9 | ) | | | 0.1 | | | | (0.2 | ) | | | (0.1 | ) | | | (0.1 | ) |
Income (loss) from discontinued operations | | | (11.3 | ) | | | (11.4 | ) | | | 0.1 | | | | (0.5 | ) | | | (1.7 | ) | | | 1.2 | |
Extraordinary item – Iraqi receivable recovery, net of $1.0 income tax | | | — | | | | — | | | | — | | | | 1.8 | | | | 1.8 | | | | — | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
NET INCOME (LOSS) | | $ | (32.9 | )* | | $ | (46.9 | )* | | $ | 14.0 | * | | $ | 28.1 | * | | $ | 0.6 | * | | $ | 27.5 | * |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
* | Amounts do not equal column totals due to rounding. |
Sales and Other Operating Revenue Supplemental Information
| | | | | | | | | | | | | | | | | | | | |
| | Nine Months Ended March 31,
| | Twelve Months Ended June 30,
|
(in millions, except per kilo amounts) | | 2004
| | Increase/ (Decrease)
| | | 2003 (unaudited)
| | 2003
| | Increase/ (Decrease)
| | | 2002
|
Tobacco sales and other operating revenues: | | | | | | | | | | | | | | | | | | | | |
Sales and other operating revenues | | $ | 764.8 | | $ | (45.0 | ) | | $ | 809.8 | | $ | 1,146.8 | | $ | (4.4 | ) | | $ | 1,151.2 |
Kilos | | | 260.4 | | | (2.9 | ) | | | 263.3 | | | 382.5 | | | 9.9 | | | | 372.6 |
Average price per kilo | | $ | 2.94 | | $ | (0.14 | ) | | $ | 3.08 | | $ | 3.00 | | $ | (0.09 | ) | | $ | 3.09 |
| | | | | | |
Processing and other revenues | | $ | 37.3 | | $ | (2.1 | ) | | $ | 39.4 | | $ | 50.7 | | $ | 9.3 | | | $ | 41.4 |
| |
|
| |
|
|
| |
|
| |
|
| |
|
|
| |
|
|
Total sales and other operating revenues | | $ | 802.1 | | $ | (47.1 | ) | | $ | 849.2 | | $ | 1,197.5 | | $ | 4.9 | | | $ | 1,192.6 |
| |
|
| |
|
|
| |
|
| |
|
| |
|
|
| |
|
|
Comparison of the Nine Months Ended March 31, 2004 to the Nine Months Ended March 31, 2003 (Unaudited)
Sales and other operating revenuesdecreased 5.5% from $849.2 million in 2003 to $802.1 million in 2004. This $47.1 million decrease is a combination of a $45.0 million decrease from sales and other operating revenues of tobacco owned and sold and a $2.1 million decrease in processing and other service revenues.
The $45.0 million decrease in sales and other operating revenues of tobacco owned and sold results from a 2.9 million kilo or 1.1% decrease in quantities sold and an $0.14 or 4.5% decrease in the average price per kilo. Sales of U.S. tobacco decreased $34.0 million and sales of non-U.S. tobacco decreased $11.0 million. The decrease in sales of U.S. tobacco was primarily due to a decrease of $26.2 million from a decrease in quantities of 4.4 million kilos as well as a decrease of $7.8 million resulting from lower average sales prices due to changes in product mix. The reduction in U.S. sales resulted from reduced sales to both U.S. and non-U.S. customers due to the higher price of U.S. tobacco relative to similar tobacco from other origins. Lower average sales prices of non-U.S. tobacco resulted in decreases of $15.0 million primarily due to both shifts in origins of tobacco and changes in product mix and was partially offset by increased sales of $4.0 million due to increased quantities. The non-U.S. tobacco sales decrease was attributable to lower sales from Brazil, Zimbabwe and Malawi partially offset by increases in European oriental and Asian tobaccos. Quantities of tobacco from Brazil were reduced due to the weather related lower crop yield as well as earlier shipments of current crop tobaccos to customers which resulted in a shift of sales into fiscal 2003. Zimbabwe tobacco quantities were reduced due to smaller crop sizes as a result of continued political interference in agricultural production. Quantities from Malawi were reduced due to less than favorable growing conditions. The increases in quantities of European oriental tobacco and Asian tobacco were due to improved customer demand. The Asian products are lower priced and have the impact of reducing the average price of non-U.S. products sold.
9
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Results of Operations(Continued)
Comparison of the Nine Months Ended March 31, 2004 to the Nine Months Ended March 31, 2003(Continued)
The $2.1 million decrease in processing and other service revenues relates to lower U.S. revenues as a result of lower quantities of customer-owned tobacco processed.
Gross profit as a percentage of sales decreased to 13.2% in 2004 compared to 16.1% in 2003. Our gross profit decreased $31.2 million to $105.5 million in 2004 from $136.7 million in 2003. This decrease was primarily due to the decreased volumes in the United States, Brazil, Zimbabwe and Malawi. Margins in Zimbabwe were further eroded by higher product costs. In addition to lower volumes, margins in the United States were negatively impacted by higher insurance costs. The increased quantities from Asia consisted of lower margin products. In Europe, increases in margin resulting from higher quantities of oriental tobacco were substantially offset by the impact of a poor oriental crop in Greece. Gross profit was also negatively impacted by the 2004 $2.1 million increase in the lower of cost or market adjustment (LCM) related to the March 31st tobacco inventories. In 2004, we recognized a $5.0 million LCM compared to $2.9 million LCM in 2003. The increased LCM in 2004 is primarily attributable to the impact of unfavorable growing conditions in Indonesia and northern Brazil on our dark tobacco operations.
Selling, administrative and general expensesincreased $11.8 million or 15.5% from $76.3 million in 2003 to $88.1 million in 2004. Personnel related costs increased a net of $5.0 million primarily due to increases in salary, retirement expense and other personnel costs offset by a decrease of $2.7 million related to incentive compensation plans. Exchange rate changes on expenses denominated in euros, sterling and real resulted in an estimated increase of $2.7 million. Legal and professional fees increased $2.1 million primarily due to Sarbanes-Oxley requirements and the compression of audit fees into the nine month fiscal year. Insurance expense increased $1.1 million due to continued higher premium charges. Other increases of $0.9 million relate primarily to travel.
Restructuring and asset impairment chargeswere $22.5 million in 2004. These charges are comprised of $20.8 million for asset impairments and $1.7 million for employee separations. See Note C to the “Notes to Consolidated Financial Statements.”
Interest expense decreased $2.1 million from $34.3 million in 2003 to $32.2 million in 2004. This change is primarily due to a $4.2 million decrease related to lower average rates offset by a $2.1 million increase related to higher average borrowings.
Interest income increased $3.9 million from $2.5 million in 2003 to $6.4 million in 2004 primarily due to higher interest rates and average cash balances in Zimbabwe.
Derivative financial instrumentsresulted in a $6.5 million benefit in 2004 compared to a $10.4 million charge in 2003. The charge or benefit relates to the changes in fair value of non-qualifying interest rate swap agreements as discussed in Note E to the “Notes to Consolidated Financial Statements.”
Effective income tax ratesof 3% in 2004 and 23% in 2003 relate primarily to the distribution of taxable income among various taxing jurisdictions as well as assumptions on the inability to utilize deferred tax assets resulting from net operating losses. In addition, the effective income tax rate in 2004 is adversely affected by deferred income tax expense related to expiring tax credits and undistributed earnings of foreign subsidiaries no longer considered permanently reinvested and by certain asset impairment charges for which no income tax benefit is realized.
Minority interestsresulted in income of $2.8 million in 2004 compared to a loss of $0.1 million in 2003. This change is primarily due to the acquisition of majority interest in an entity previously reported using the equity method of accounting. This entity had losses, including impairment charges, which resulted in an allocation to minority interest shareholders of $2.8 million. See Note C to the “Notes to Consolidated Financial Statements.”
Loss from discontinued operations was $11.3 million in 2004 compared to income of $0.1 million in 2003. The loss in 2004 includes $6.9 million of fixed asset impairment charges, an increase of $2.3 million in lower of cost or market adjustments and a reduction in gross profit on the 2004 sales from Italy of $1.3 million. All of these amounts relate to the discontinuance of our Italian operations. Also, see Note B to the “Notes to Consolidated Financial Statements.”
Comparison of the Year Ended June 30, 2003 to the Year Ended June 30, 2002
Sales and other operating revenuesincreased 0.4% from $1,192.6 million in 2002 to $1,197.5 million in 2003. This $4.9 million increase is a combination of a $4.4 million decrease from sales and other operating revenues of tobacco owned and sold and a $9.3 million increase in processing and other service revenues.
10
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Results of Operations(Continued)
Comparison of the Year Ended June 30, 2003 to the Year Ended June 30, 2002(Continued)
The $4.4 million decrease in sales and other operating revenues of tobacco owned and sold results from a $0.09 or 2.9% decrease in the average price per kilo partially offset by a 9.9 million kilo or 2.7% increase in quantities sold. This change results from increases in quantities and average prices of non-U.S. tobacco offset by decreases in quantities and average prices of U.S. tobacco. The sales and other revenues of U.S. tobacco decreased $80.5 million partially offset by a $76.1 million increase from non-U.S. tobacco. Quantities of non-U.S. tobacco, primarily due to earlier shipments from Brazil, increased 21.5 million kilos over the prior year resulting in increased revenues of $57.0 million. Quantities from our African operations were minimally impacted by decreases in the Zimbabwe crop size as quantities from other countries in the region increased. Average prices of non-U.S. tobacco increased resulting in a $19.1 million increase over the prior year due to changes in product mix as the greater quantities consisted of higher priced product. Quantities of U.S. tobacco sold decreased 11.6 million kilos over the previous year resulting in a $70.5 million decrease in sales. The decrease in the U.S. quantities was primarily due to reduced sales to non-U.S. customers and non-recurring 2002 sales of prior crop tobacco. Average prices of U.S. tobacco decreased resulting in a $10.0 million decrease primarily due to product mix as the reduction in quantity were also comprised of higher priced product.
The $9.3 million increase in processing and other service revenues relates primarily to higher quantities of customer owned tobacco processed in the U.S.
Gross profit as a percentage of sales increased to 17.1% in 2003 compared to 16.6% in 2002. Our gross profit increased $6.9 million to $205.3 million in 2003 from $198.4 million in 2002. This increase was primarily due to the increased volume in Brazil, which was partially offset by lower volumes of U.S. tobacco sold to non-U.S. customers. The increase in gross profit is also due to charges recognized in 2002 of $2.9 million related to devaluation of the Argentine peso partially offset by a gain of $1.7 million realized in 2002 related to the sale of unutilized Zimbabwe assets. In Africa, gross profit decreases in Zimbabwe were offset by increased gross profit from Malawi and Tanzania. In Europe, gross profit decreased as costs increased due to the strength of the euro.
Selling, administrative and general expenses increased $5.9 million or 5.5% from $107.7 million in 2002 to $113.6 million in 2003. This increase is primarily due to $7.8 million in increased legal and professional fees substantially due to the recognition of $6.0 million in settlement of the DeLoach class action lawsuit and increases due to related legal fees, increases in retirement expense of $3.3 million primarily due to changes in defined benefit and postretirement plan actuarial assumptions including the rate of return assumption on cash balance plan assets, insurance expense increases of $1.5 million due to changes in business risk related to events that have occurred in recent years and an estimated $2.2 million impact from exchange rate changes on expenses denominated in euros and sterling. These increases were somewhat offset by the adoption of SFAS No. 142 in 2003 that resulted in cessation of goodwill amortization that was $6.5 million in 2002 as well as decreases of $3.2 million in incentive compensation awards that are related directly to our operating results.
Interest expense decreased $1.0 million from $47.9 million in 2002 to $46.9 million in 2003. This change is primarily due to a $14.6 million decrease related to lower average rates offset by a $13.6 million increase related to higher average borrowings partially resulting from the effect of carrying $125 million of redundant debt during the thirty-day call period associated with the refinancing transaction completed in May 2003.
Interest income decreased $1.0 million from $3.9 million in 2002 to $2.9 million in 2003 primarily due to lower average cash balances.
Derivative financial instruments expense increased $2.2 million from 2002 to 2003. This charge relates to the changes in fair value of non-qualifying interest rate swap agreements as discussed in Note E of the “Notes to Consolidated Financial Statements.”
Effective income tax rates of 26% in 2003 and 27% in 2002 relate primarily to the distribution of taxable income among various taxing jurisdictions. Changes in the rate from 2002 to 2003 are also partially attributable to the non-amortization of goodwill in 2003.
Loss from discontinued operationswas $0.5 million in 2003 compared to income of $1.2 million in 2002. The loss in 2003 and the income in 2002 related to the discontinuance of Italian operations. Also, see Note B to the “Notes to Consolidated Financial Statements.”
Extraordinary Item –On May 1, 2003, the Company received $2.7 million from the United Nations Compensation Commission in connection with a claim filed by a predecessor company, Monk-Austin, Incorporated. The claim arose from an uncollected trade receivable from the Iraqi Tobacco Monopoly, which related to transactions that occurred prior to Iraq’s invasion of Kuwait in August 1990. The extraordinary gain of $1.8 million is recorded net of tax of $0.9 million.
11
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Liquidity and Capital Resources
The following table is a summary of items from the Consolidated Balance Sheet and the Statement of Consolidated Cash Flows.
| | | | | | | | | |
(in millions, except for current ratio) | | Nine Months Ended March 31, 2004
| | Years Ended June 30,
|
| | 2003
| | 2002
|
Cash and cash equivalents | | $ | 18.8 | | $ | 88.9 | | $ | 109.0 |
Net trade receivables | | | 192.8 | | | 172.9 | | | 165.7 |
Inventories and advances on purchases of tobacco | | | 556.6 | | | 512.3 | | | 464.9 |
Total current assets | | | 865.6 | | | 848.3 | | | 799.9 |
Notes payable to banks | | | 243.7 | | | 210.2 | | | 181.6 |
Accounts payable | | | 65.9 | | | 70.9 | | | 73.7 |
Total current liabilities | | | 445.9 | | | 404.5 | | | 363.9 |
Current ratio | | | 1.9 to 1 | | | 2.1 to 1 | | | 2.2 to 1 |
Revolving Credit Notes and Other Long-Term Debt | | | 11.9 | | | 10.3 | | | 7.5 |
Convertible Subordinated Debentures | | | 73.3 | | | 73.3 | | | 73.3 |
Senior Notes | | | 335.8 | | | 341.3 | | | 321.4 |
Stockholders’ equity | | | 414.9 | | | 454.6 | | | 434.7 |
Purchase of property and equipment | | | 25.7 | | | 28.0 | | | 19.7 |
Proceeds from sale of property and equipment | | | 1.4 | | | 2.7 | | | 5.9 |
Depreciation and amortization | | | 26.3 | | | 34.5 | | | 41.2 |
The purchasing and processing activities of our business are seasonal. Our need for capital fluctuates accordingly and, at any one of several seasonal peaks, our outstanding indebtedness may be significantly greater or less than at year end. We historically have needed capital in excess of cash flow from operations to finance inventory and accounts receivable. We also prefinance tobacco crops in numerous foreign countries, including Argentina, Brazil, Canada, Greece, Guatemala, Indonesia, Malawi, Mexico, Mozambique, Tanzania, Thailand and Turkey, by making advances to growers and grower co-operatives prior to and during the growing season.
Our working capital decreased from $443.8 million at June 30, 2003 to $419.7 million at March 31, 2004. Our current ratio was 1.9 to 1 at March 31, 2004 compared to 2.1 to 1 at June 30, 2003. At March 31, 2004, our current assets had increased $17.3 million and current liabilities had increased $41.4 million from June 30, 2003. The $17.3 million increase in current assets is primarily due to a $44.3 million increase in inventories and advances on purchases of tobacco, a $19.9 million increase in accounts receivable, a $17.2 million increase in assets of discontinued operations, and a $2.8 million increase in current deferred and recoverable income taxes partially offset by a $70.1 million decrease in cash. The $41.4 million increase in current liabilities relates primarily to increases of $33.5 million in notes payable to banks, a $6.3 million increase in advances from customers, a $4.7 million increase in accrued expenses and a $2.7 million increase in liabilities of discontinued operations. The increase in inventories and advances on purchases of tobacco relates to build up of inventories as European crops have not yet completed the sales cycle and South American inventories are in production. Increases in inventory and advances on purchases in Europe and South America were partially offset by decreases in Africa. The changes in cash and notes payable to banks are related to financing the higher inventory and advance levels at March 31, 2004 compared to June 30, 2003 and a net loss in 2004 compared to net income in 2003. Changes in assets and liabilities of discontinued operations relate to the sale of our Italian processing facility and our simultaneous decision to cease operations in Italy. The build up of assets in discontinued operations during the year relates to the local crop cycle and the normal seasonal accumulation of inventory as the decision to discontinue was not made until the conclusion of the buying cycle.
Cash used by operating activities was $54.8 million in 2004 compared to cash provided of $7.6 million in 2003 and $65.1 million in 2002. The decrease in cash flows from operations in 2004 compared to 2003 is due primarily to $60.9 decrease in net income, $22.6 more cash used for operating activities of discontinued operations, $14.4 more cash used to finance accounts receivable, $16.0 million change in deferred items and $8.3 million less non-cash depreciation and amortization charges partially offset by $24.5 million less cash used for inventories and advances on purchases of tobacco, non-cash restructuring and asset impairment charges of $22.5 million and a $10.8 million increased loss from discontinued operations. The increases in accounts receivable relate to Europe, North America and Africa and the relative position of the crop cycles. Changes in deferred items relate primarily to deferred taxes and the increase in non-current deferred tax assets related to current year operating losses. The decrease in cash flows from operations in 2003 compared to 2002 was due primarily to $27.7 million more cash used for inventory and advances on purchases of tobacco, $16.8 million more cash used for accounts payable and accrued expenses, $9.7 million less cash provided by accounts receivable, $6.7 million less non-cash charges from depreciation and amortization, $6.0 million less changes in deferred items and $5.4 million more cash used by discontinued operations partially offset by $13.0 million more cash provided by advances from customers. The changes in inventory and advances on purchases of tobacco, accounts payable and accrued expenses, accounts receivable and advances from customers, in 2003 compared to 2002, are primarily due to higher levels of inventory committed to customers. The change in depreciation and amortization relates to the cessation of amortization of goodwill due to the adoption of SFAS 142. Changes in deferred items related primarily to changes in deferred income taxes.
12
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Liquidity and Capital Resources(Continued)
Cash flows used by investing activities were $28.2 million in 2004, $31.2 million in 2003 and $10.5 million in 2002. The decrease in cash used for investing activities in 2004 compared to 2003 is primarily due to $4.1 million used in 2003 to purchase a 75% interest in an Indonesian tobacco processing subsidiary, $5.0 million used to purchase a 25% interest in a North Carolina company that purchases, processes and sells kenaf, a renewable agricultural product, $2.2 million lower purchases of property and equipment and $1.6 million of other changes related to Brazilian escrow taxes and life insurance premiums. The decreases in cash used were partially offset by net changes in notes receivable of $7.1 million due primarily to notes issued in regard to the current Argentine and Brazilian crops, $1.5 million used for purchase of an additional 32.5% interest in the kenaf business and $1.4 million less cash provided from sales of property and equipment. The increased cash used in investing activities in 2003 compared to 2002 is due in part to $8.3 million higher purchases of property and equipment and $3.1 million lower proceeds from the sale of property and equipment. In addition, in 2003, there was a $5.0 million purchase of 25% interest in a company in North Carolina and a $4.1 million purchase of a 75% interest in an Indonesian company. Other uses of cash amounted to $0.2 million and relate primarily to life insurance premiums and Brazilian escrow taxes paid, offset in part by tax deposits recovered in Italy.
Cash flows from financing activities provided $13.5 million in 2004 compared to $2.4 million in 2003 and $36.4 million in 2002. The greater provision of cash in 2004 compared to 2003 is due to $6.8 million increase in short term borrowings, $2.1 million less dividends paid to stockholders, lower debt issuance costs of $1.1 million related to instruments discussed below and $0.7 million proceeds from the exercise of stock options. The increase in cash from short term borrowings relates to financing higher levels of accounts receivable and inventory. The decrease in dividends relates to the current nine month transitional fiscal year compared to a twelve month fiscal year in 2003. The lower provision of cash in 2003 compared to 2002 is due to issuance of $125 million Senior Notes in 2003 compared to issuance of $200 million Senior notes in 2002 and a $165 million syndicated bank credit facility that was entered into in 2002. The decreased provisions from 2002 to 2003 were partially offset by repayments of borrowings in 2002 that were issued under an older $250 million credit facility.
At March 31, 2004, we had seasonally adjusted lines of credit of $594.3 million of which $243.7 million was outstanding with a weighted average interest rate of 2.99%. Unused short-term lines of credit amounted to $305.1 million. At March 31, 2004, we had $35.5 million of letters of credit outstanding and an additional $10.0 million of letters of credit lines available. Total maximum borrowings, excluding the long-term credit agreements, during the fiscal year were $349.2 million.
Cash dividends paid to stockholders during 2004 remained at $.075 per share per quarter.
Availability of Short-Term Uncommitted Bank Credit Facilities
We generally rely on a broad group of global and regional lenders to provide economical crop financing in each significant source country. The availability of such credit facilities can be negatively affected by ongoing consolidation within the banking industry, changing lender policies regarding the tobacco industry, and geopolitical instability. To mitigate the risk associated with our reliance on short-term uncommitted bank credit facilities, we have accessed capital markets to obtain long-term debt funding, and maintain a substantially undrawn syndicated bank facility.
Customer Arrangements For Committed Inventories
We hold substantial amounts of inventories that are committed to specific customers and, to the extent that those customers do not provide advance funding, we must provide financing for such inventories. We have experienced a trend of increasing levels of customer funding for committed inventories in recent years. However, a reversal of that trend could negatively affect our short-term liquidity.
Long Term Debt
During fiscal years 2002 and 2003 we completed two strategic refinancing transactions that, in aggregate, have expanded our sources and available amounts of liquidity, extended the average maturity of our debt portfolio from 3.2 years to 8.0 years, and significantly reduced our dependence on short-term uncommitted debt facilities.
On October 30, 2001, we issued $200 million principal amount of 9 5/8% Senior Notes due 2011. The proceeds of this Note issuance were used to repay certain existing indebtedness, including all amounts drawn under our $250 million syndicated credit facility then existing. The financial covenants of the Senior Notes are substantially similar to those for the $125 million principal amount of 8 7/8% Senior Notes due 2006, that were outstanding at that time. Concurrent with the completion of the Note issuance, we entered into a derivative financial instrument to swap the entire $200 million notional amount to a floating interest rate equal to LIBOR plus 4.11%, set six months in arrears. The effective rate at March 31, 2004 was 5.27%.
13
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Liquidity and Capital Resources(Continued)
Long Term Debt (Continued)
On May 30, 2003, we issued $125 million principal amount of 7 3/4% Senior Notes due 2013. The proceeds of this Note issuance were used to redeem in full $125 million of our outstanding 8 7/8% Senior Notes due 2006. The financial covenants of the Senior Notes are substantially similar to those for the aforementioned $200 million principal amount of 9 5/8% Senior Notes due 2011. Concurrent with the completion of the Note issuance, we entered into a derivative financial instrument to swap the entire $125 million notional amount to a floating interest rate equal to LIBOR plus 3.69%, set six months in arrears. The effective rate at March 31, 2004 was 4.85%. The existing 8 7/8% Senior Notes due 2006 were fully redeemed at June 30, 2003.
The indentures governing our Senior Notes contain certain covenants that, among other things, limit our ability to (i) transfer or issue shares of capital stock of subsidiaries to third parties, (ii) pay dividends or make certain other payments, (iii) incur additional indebtedness, (iv) issue preferred stock, (v) incur liens to secure our indebtedness, (vi) apply net proceeds from certain asset sales, (vii) enter into certain transactions with affiliates, (viii) merge with or into any other person or (ix) enter into certain sale and leaseback transactions.
On October 27, 2003, we completed a new three-year $150 million syndicated bank credit facility with a group of seven banks. The credit facility is subject to certain commitment fees and covenants that, among other things, require us to maintain minimum working capital and tangible net worth amounts, require specific liquidity and long-term solvency ratios, including certain borrowing base restrictions, and restrict acquisitions. We continuously monitor our compliance with these covenants. At December 31, 2003 our consolidated fixed charge coverage ratio was 1.14 to 1, which was below the required covenant hurdle of 1.20 to 1. We obtained, with unanimous approval from the lender banks, a waiver for the December 31, 2003 covenant together with an amendment resetting the required hurdle in future periods to 1.00 to 1 through the period ending September 29, 2004. At March 31, 2004, our consolidated fixed charge coverage ratio was 0.969 to 1, which was below the amended covenant hurdle of 1 to 1. We obtained a waiver from the lender banks for the March 31, 2004 covenant together with an amendment resetting the required hurdle in future periods to 0.75 to 1 through the period ending September 29, 2004; 0.90 to 1 for the period from September 30 to December 30, 2004; and 1.05 to 1 for the period from December 31, 2004 through March 30, 2005. Thereafter, the hurdle returns to its originally defined level of 1.25 to 1 for the remainder of the facility’s term.
The credit facility’s initial term expires on October 26, 2006, and, subject to approval by the lenders, may be extended. The rates of interest are based on our published credit rating and vary according to the type of loan requested by us. During the life of the agreement, the interest rate could be the prime rate or the LIBOR rate adjusted. The primary advance rate is the agent bank’s base lending rate, 4% at March 31, 2004. We pay a commitment fee of 1% per annum on any unused portion of the facility. The new facility replaced a $165 million facility.
For all of the derivative financial instruments mentioned above, the notional amount, maturity, and payment dates of the derivative financial instruments match those of the Notes. In accordance with Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” the derivatives qualify for hedge accounting treatment. See also Note E to the “Notes to Consolidated Financial Statements.”
We have historically financed our operations through a combination of short-term lines of credit, revolving credit arrangements, customer advances, cash from operations and equity and equity-linked securities. At March 31, 2004, we had capital expenditure commitments of $2.0 million. We believe that these sources of funds will be sufficient to fund our anticipated needs for fiscal year 2005. There can be no assurance, however, that these sources of capital will be available in the future or, if available, that any such sources will be available on favorable terms.
Aggregate Contractual Obligations and Off-Balance Sheet Arrangements
We have summarized in the table below our contractual cash obligations and other commercial commitments as of March 31, 2004.
| | | | | | | | | | | | | | | |
| | Payments / Expirations by Period
|
(in millions) | | Total
| | Year 1
| | Years 2-3
| | Years 4-5
| | More than 5 years
|
Long Term Debt | | $ | 419.7 | | $ | 2.4 | | $ | 76.8 | | $ | 1.7 | | $ | 338.8 |
Capital Lease Obligations | | | 5.3 | | | 0.8 | | | 1.5 | | | 1.4 | | | 1.6 |
Operating Leases | | | 28.5 | | | 5.8 | | | 7.4 | | | 3.2 | | | 12.1 |
Capital Expenditure Commitments | | | 2.0 | | | 2.0 | | | — | | | — | | | — |
Tobacco Purchase Obligations | | | 531.8 | | | 442.3 | | | 89.5 | | | — | | | — |
Grower Financing Guarantees | | | 142.3 | | | 90.5 | | | 33.8 | | | 14.8 | | | 3.2 |
| |
|
| |
|
| |
|
| |
|
| |
|
|
Total Contractual Obligations and Other Commercial Commitments | | $ | 1,129.6 | | $ | 543.8 | | $ | 209.0 | | $ | 21.1 | | $ | 355.7 |
| |
|
| |
|
| |
|
| |
|
| |
|
|
14
|
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS(Continued) Liquidity and Capital Resources(Continued) Aggregate Contractual Obligations and Off-Balance Sheet Arrangements(Continued) We do not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources, as defined under the rules of SEC Release No. FR-67. Lease Obligations We have both capital and operating leases. In accordance with accounting principles generally accepted in the United States, operating leases are not reflected in the accompanying Consolidated Balance Sheet. The operating leases are for land, buildings, automobiles and other equipment; the capital leases are primarily for production machinery and equipment. The capitalized lease obligations are payable through 2010. Operating assets that are of long-term and continuing benefit are generally purchased. Tobacco Purchase Obligations and Grower Financing Guarantees Tobacco purchase obligations result from contracts with growers, primarily in the United States, Brazil and Malawi, to buy either specified quantities of tobacco or the grower’s total tobacco production. Amounts shown as tobacco purchase obligations are estimates based on projected purchase prices of the future crop tobacco. Payment of these obligations is net of our advances to these growers. Our tobacco purchase obligations do not exceed our projected requirements over the related terms and are in the normal course of business. In certain non-U.S. markets, we provide growers and grower cooperatives with materials necessary to grow tobacco and may either directly loan or guarantee bank loans to growers to finance the crop. Under longer-term arrangements, we may also finance or guarantee financing on growers’ construction of curing barns or other tobacco production assets. We are obligated to repay any guaranteed loan should the grower default. See also Note O to the “Notes to Consolidated Financial Statements.” Planned Capital Expenditures We have projected a total of $18.6 million in capital investments for the coming year. We forecast our capital expenditure needs for routine replacement of equipment as well as investment in assets that will add value to the customer or increase efficiency. Purchase commitments of $2.0 million are included in these expenditures at March 31, 2004. Tax and Repatriation Matters We are subject to income tax laws in each of the countries in which we do business through wholly owned subsidiaries and through affiliates. We make a comprehensive review of the income tax requirements of each of our operations, file appropriate returns and make appropriate income tax planning analyses directed toward the minimization of our income tax obligations in these countries. Appropriate income tax provisions are determined on an individual subsidiary level and at the corporate level on both an interim and annual basis. These processes are followed using an appropriate combination of internal staff at both the subsidiary and corporate levels as well as independent outside advisors in review of the various tax laws and in compliance reporting for the various operations. We consider unremitted earnings of subsidiaries operating outside the United States to be invested indefinitely. No U.S. income taxes or foreign withholding taxes are provided on such permanently reinvested earnings, in accordance with APB 23,”Accounting for Income Taxes, Special Area.” We regularly review the status of the accumulated earnings of each of our foreign subsidiaries and reassess this determination as part of our overall financing plans. Following this assessment, we provide deferred income taxes, net of any foreign tax credits, on any earnings that are determined to no longer be indefinitely invested. Factors that May Affect Future Results The following important factors, among other things, in some cases have affected, and in the future could affect, our actual operating and financial results and could cause our actual results for 2005 and beyond to differ materially from those expressed in any forward-looking statements made by us. Risks Relating To Our Operations Global shifts in sourcing customer requirements may negatively impact our operating results. |
The global leaf tobacco industry is currently experiencing shifts in the sourcing of customer requirements for tobacco. For example, significant tobacco production volume decreases have occurred and may continue to occur in the United States and Zimbabwe, and we expect future reductions in volume will occur in Western Europe. At the same time, production volumes in other sourcing origins, such as Brazil, continue to grow. |
15
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS(Continued)
Risks Relating To Our Operations (Continued)
This shift in sourcing origins in Europe may be exacerbated by recent modifications to the tobacco price support system in the European Union (“EU”). The Agricultural Counsel of the EU recently implemented changes in the quota and volume programs across the EU that may result in material reductions in production volumes in certain EU countries after 2006. The implementation of these new programs will vary significantly by each EU country, decreasing our ability to plan effectively for the longer term in Europe.
We may not be able to timely or efficiently adjust to these shifts in sourcing origins, and adjusting to these shifts may require changes in our production facilities in certain origins and changes of our fixed asset base. We have incurred, and may continue to incur, restructuring charges as we continue to adjust to these shifts in sourcing. Adjusting our capacity and adjusting to these shifts in sourcing may have an adverse impact on our ability to manage our costs, and could have an adverse effect on our financial performance and results of operations.
Our financial results will vary according to growing conditions, customer indications and other factors, which also reduces your ability to gauge our performance and increases the risk of an investment in our securities.
Our financial results, particularly the quarterly financial results, may be significantly affected by fluctuations in tobacco growing seasons and crop sizes. The cultivation period for tobacco is dependent upon a number of factors, including the weather and other natural events, such as hurricanes or tropical storms, and our processing schedule and results of operations can be significantly altered by these factors.
Further, the timing and unpredictability of customer indications, orders and shipments causes us to keep tobacco in inventory, increases our risk and results in variations in quarterly and annual financial results. In addition, reduced levels of imports into Brazil have resulted in a shortage of shipping containers and vessels available for tobacco and other exports. These shipping delays could impact the timing of shipments between quarters in fiscal 2005. We may from time to time in the ordinary course of business keep a significant amount of processed tobacco in inventory for our customers to accommodate their inventory management and other needs. Sales recognition by us and our subsidiaries is based on the passage of ownership, usually with shipment of product. Since individual shipments may represent significant amounts of revenue, our quarterly and annual financial results may vary significantly depending on our customers’ needs and shipping instructions.
These fluctuations result in varying volumes and sales in given periods, which also reduces your ability to compare our financial results in different periods or in the same periods in different years.
Our adoption and application of certain standards in financial accounting could cause our annual and quarterly financial results to vary and will reduce your ability to gauge our performance, increasing the risk of an investment in our securities.
Effective July 1, 2000, we adopted Statement of Financial Accounting Standards (SFAS) No. 133, “Accounting for Derivative Instruments and Hedging Activities.” As a result of adoption of SFAS No. 133, we recognize all derivative financial instruments, such as interest rate swap contracts and foreign exchange contracts, in the consolidated financial statements at fair value regardless of the purpose or intent for holding the instrument. We use forward contracts to mitigate our exposure to changes in foreign currency exchange rates on forecasted transactions. The effective portion of unrealized gains and losses associated with forward contracts and the intrinsic value of option contracts are deferred as a component of accumulated other comprehensive income until the underlying hedge transactions are reported on our consolidated statement of earnings. We have traditionally used interest rate swaps to mitigate our exposure to changes in interest rates related to certain debt agreements. The swaps convert floating-rate debt to fixed-rate debt. Interest rate swaps, to the extent they are effective hedges, are accounted for as cash flow hedges, with the changes in the fair values of these instruments being recorded in accumulated other comprehensive income net of deferred taxes. Changes in the fair values of derivatives not qualifying as hedges are reported in net income. As a result of fluctuations in interest rates and volatility in market expectations, the fair market value of interest rate swap instruments can be expected to appreciate or depreciate over time. We plan to continue the practice of economically hedging various components of our debt. However, as a result of SFAS No. 133, certain swap instruments have and may continue to create volatility in future reported earnings. See Note E to the “Notes to Consolidated Financial Statements.”
16
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Risks Relating To Our Operations(Continued)
The shift to direct contract buying of green tobacco by many of our U.S. customers affects your ability to compare our year to year results and could have an adverse effect on our results of operations.
Comparability of our sales revenues has been affected by the shift to direct contract buying in the United States. In the United States, prior to 2002, we took ownership of all green tobaccos we purchased, then processed and resold that tobacco to our customers. Concurrent with the shift from an auction system to a direct contract buying system in the United States, certain major U.S. customers began purchasing green tobacco directly from the growers. We no longer take ownership of that tobacco and no longer record revenues associated with its resale. To the extent that the auction market in the United States continues to represent a smaller portion of overall tobacco purchases in the U.S., we could be forced to buy more tobacco directly from growers under contracts that require us to buy a particular grower’s total crop, potentially elevating our levels of uncommitted inventories. When we purchase under an auction system, we continue to purchase tobaccos primarily to match specific customer orders. We continue to need buying personnel for these residual auction markets, which could affect our ability to manage our costs.
Our extension of credit to tobacco growers could have an adverse effect on our financial condition.
We make advances to tobacco growers in many countries to finance their growing of tobacco for sale to us. Crop advances to growers are generally secured by the grower’s agreement to deliver green tobacco. In the event of crop failure, recovery of advances could be delayed until deliveries of future crops or indefinitely. The temporary or permanent loss of these advances to growers could have a material adverse effect on our financial condition or results of operations.
Competition could adversely affect our operating results.
The leaf tobacco industry is highly competitive. Competition among leaf tobacco merchants is based primarily on the price charged for products and services as well as the merchant’s ability to meet customer specifications in the buying, processing and financing of tobacco. In addition, there is competition in all countries to buy the available tobacco and in many areas, total leaf tobacco processing capacity exceeds demand. There are three major global independent leaf tobacco merchants, and they are dependent upon a few large tobacco manufacturing customers. The number of manufacturers has declined in recent years due to consolidation. The loss of, or a substantial reduction in the services provided to, any large or significant customer could have a material adverse effect on our financial condition or results of operations.
In addition to the three primary global independent leaf tobacco merchants, the cigarette manufacturers increasingly buy tobacco directly from farmers, and other industry players are entering the leaf purchasing and processing business. We face increasing competition from new local and regional independent leaf merchants with low fixed costs and overhead and good customer connections at the local level. These new independent merchants are buying an increasing portion of the crops in certain international markets, particularly Brazil, where the new entrants have been able to capitalize in the global transition to that market. In the United States, the Flue-Cured Tobacco Stabilization Cooperative (“FCTSC”) has announced its intention to purchase the Vector facility in Roxboro, North Carolina. That facility will enable the FCTSC to process tobacco and manufacture cigarettes. Any of these sources of new competition may result in less tobacco available for us to purchase and process in the applicable markets.
Our reliance on a small number of significant customers may adversely affect our results of operations.
Our customers are manufacturers of cigarette and other tobacco products. Several of these customers individually account for a significant portion of our sales in a normal year. Of our consolidated tobacco sales in 2004, 2003 and 2002, approximately 17%, 21% and 22%, respectively, were to various tobacco customers which we have been led to believe are owned by or under common control of Japan Tobacco Inc. and approximately 19%, 18% and 14%, respectively, were to various tobacco customers which we have been led to believe are owned by or under common control of Altria Group, Inc. In addition, tobacco product manufacturers are currently experiencing a period of consolidation (including the pending merger of R.J. Reynolds Tobacco Holdings and Brown & Williamson), and further consolidation among our customers could decrease such customer’s demand for our leaf tobacco or processing services. The loss of any one or more of such customers could have a material adverse effect on our financial condition or results of operations.
We face increased risks of doing business due to the extent of our international operations.
We do business in over 40 countries, many of which do not have stable economies or governments. Our international operations are subject to international business risks, including unsettled political conditions, expropriation, import and export restrictions, exchange controls, inflationary economies and currency risks and risks related to the restrictions on repatriation of earnings or proceeds from liquidated assets of foreign subsidiaries. These risks are exacerbated in countries where we have advanced substantial sums or guaranteed local loans or lines of credit for the purchase of tobacco from growers.
17
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Risks Relating To Our Operations(Continued)
We have significant investments in our purchasing, processing and exporting operations in Brazil, Malawi, Tanzania, Zimbabwe, Turkey and Thailand. In particular, we derive significant operating profit from our operations in Brazil and Zimbabwe. In recent years, these countries’ economic problems have received wide publicity related to devaluation of the local currency and inflation. Devaluation and appreciation of local currencies can affect our purchase costs of tobacco and our processing costs.
In addition, we do business in countries that have tax regimes in which the rules are not clear or not consistently applied. This is especially true with regard to international transfer pricing.
We face increased risk of doing business in Zimbabwe due to political instability and civil unrest.
Zimbabwe remains in a period of civil unrest in combination with a deteriorating economy. Should the current political situation continue, we could experience disruptions and delays associated with our Zimbabwe operations. The government’s forced land resettlement program has caused disruptions to both tobacco and food farm production in Zimbabwe. The volume of the 2003 tobacco crop declined by approximately 49% in comparison to the prior year crop from 165 to 85 million kilos. The 2004 crop is projected to decrease to 60 million kilos; however, we are expecting to buy, process and sell an equivalent quantity as we did for the 2003 crop year. If the political situation in Zimbabwe continues to deteriorate, our ability to recover our assets there could be impaired. See Note C to the “Notes to Consolidated Financial Statements.” Our Zimbabwe subsidiary has long-lived assets of approximately $39.7 million as of March 31, 2004.
Fluctuations in foreign currency exchange and interest rates could adversely affect our results of operations.
Local country operating costs, including the purchasing and processing costs for tobaccos, are subject to the effects of exchange fluctuations of the local currency against the U.S. dollar. We attempt to minimize such currency risks by matching the timing of our working capital borrowing needs against the tobacco purchasing and processing funds requirements in the currency of the country where the tobacco is grown. Fluctuations in the value of foreign currencies can significantly affect our operating results.
In addition, the devaluation of foreign currencies, particularly Asian and Eastern European currencies, has resulted and may in the future result in reduced purchasing power from customers in these areas. We may incur a loss of business as a result of the devaluation of these currencies now or in the future.
Various outstanding interest-bearing instruments are sensitive to changes in interest rates. With respect to our variable-rate debt, a 10% change in interest rates would have the effect of increasing or decreasing interest expense by $1.7 million.
Our indentures and credit agreements contain, and in the future could contain additional, covenants and tests that would limit our ability to take actions or cause us to take actions we may not normally take.
Our existing indentures and credit agreements contain a number of significant covenants. These covenants will limit our ability to, among other things:
| • | borrow additional money; |
| • | make capital expenditures and other investments; |
| • | merge, consolidate or dispose of our assets; |
| • | acquire assets in access of certain dollar amounts; and |
| • | grant liens on our assets. |
Our credit facility and existing indentures require, and any future indenture may require, us to meet certain financial tests. The failure to comply with these covenants and tests would cause a default under those agreements. A default, if not waived, could result in the debt under our credit facility and indentures becoming immediately due and payable and could result in a default or acceleration of our other indebtedness with cross-default provisions. If this occurs, we may not be able to pay our debt or borrow sufficient funds to refinance it. Even if new financing is available, it may not be on terms that are acceptable to us. Complying with these covenants and tests may cause us to take actions that we otherwise would not take or not take actions that we otherwise would take.
18
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS (Continued)
Risks Relating to the Tobacco Industry
Provisions in our indentures restrict our ability to make payments, including payments of dividends to our shareholders.
Under the terms of the Indentures relating to our 9 5/8% Senior Notes due 2011 and 7 3/4% Senior Notes due 2013, we will not be permitted to make certain payments that are restricted by such Indentures, including cash dividends on our common stock. We generally may make such restricted payments, provided that (1) we are not in default under the Indentures, (2) we are able to incur at least $1.00 of additional indebtedness under a consolidated interest coverage ratio test set forth in the Indentures, and (3) the aggregate amount of the payments to be made is less than the total of (x) $20.0 million, (y) 50% of our consolidated net income for the period from April 1, 1996, through the end of our most recent fiscal quarter and (z) the net cash proceeds from our sale of any equity securities or debt securities that are converted into equity securities, which at March 31, 2004 and June 30, 2003, was $30.0 million and $39.4 million, respectively.
Reductions in demand for consumer tobacco products could adversely affect our results of operations.
The tobacco industry, both in the United States and abroad, continues to face a number of issues that may reduce the consumption of cigarettes and adversely affect our business, sales volume, results of operations, cash flows and financial condition.
These issues, some of which are more fully discussed below, include:
| • | governmental actions seeking to ascribe to tobacco product manufacturers liability for adverse health effects associated with smoking and exposure to environmental tobacco smoke; |
| • | smoking and health litigation against tobacco product manufacturers; |
| • | tax increases on consumer tobacco products; |
| • | current and potential actions by state attorneys general to enforce the terms of the Master Settlement Agreement (“MSA”) between state governments in the United States and tobacco product manufacturers; |
| • | governmental and private bans and restrictions on smoking; |
| • | actual and proposed price controls and restrictions on imports in certain jurisdictions outside the United States; |
| • | restrictions on tobacco product manufacturing, marketing, advertising and sales; |
| • | the diminishing social acceptance of smoking; |
| • | increased pressure from anti-smoking groups; and |
| • | other tobacco product legislation that may be considered by Congress, the states and other countries. |
Tobacco product manufacturer litigation may reduce demand for our services.
Our primary customers, the leading cigarette manufacturers, face thousands of lawsuits brought throughout the United States and, to a lesser extent, the rest of the world. The effects of the lawsuits on our customers could reduce their demand for tobacco from us. These lawsuits have been brought by plaintiffs, including (1) individuals and classes of individuals alleging personal injury and/or misleading advertising, (2) governments (including governmental and quasi-governmental entities in the United States and abroad) seeking recovery of health care costs allegedly caused by cigarette smoking, and (3) other groups seeking recovery of health care expenditures allegedly caused by cigarette smoking, including third-party health care payors, such as unions and health maintenance organizations. Damages claimed in some of the smoking and health cases range into the billions of dollars. In September 1999, the United States Department of Justice filed a lawsuit against the leading cigarette manufacturers, seeking to recover billions of dollars. There have been several jury verdicts in tobacco product litigation during the past several years. Additional plaintiffs continue to file lawsuits.
19
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Risks Relating to the Tobacco Industry (Continued)
In November 1998, certain United States tobacco product manufacturers entered into the MSA with 46 states and certain territories to settle asserted and unasserted health care cost recovery and other claims. These manufacturers had previously settled similar claims brought by Mississippi, Florida, Texas and Minnesota and an environmental tobacco smoke and health class action brought on behalf of airline flight attendants. The MSA has received final judicial approval in all 52 settling jurisdictions.
Key provisions of the MSA are as follows:
| • | payments of approximately $206 billion over 25 years from the cigarette manufacturers to the states; |
| • | marketing and advertising restrictions, including bans on cartoon characters, point-of-sale advertising, billboards, bus and taxi placards and sponsorships of most sporting events by brand names; |
| • | disbanding the Tobacco Institute, the Council for Tobacco Research and the Council for Indoor Air Research; |
| • | eliminating vending machine sales and requiring that all tobacco products be behind a counter; and |
| • | making payments of $1.7 billion for educational efforts about the dangers of smoking and to discourage youth smoking. |
The MSA and other state settlement agreements include provisions relating to advertising and marketing restrictions, public disclosure of industry documents, limitations on challenges to tobacco product control and underage use laws, lobbying activities and other provisions. The provisions of the Master Settlement Agreement and any similar settlement agreements could have a material adverse impact on our customer’s purchase from us.
Legislative and regulatory initiatives could reduce consumption of consumer tobacco products and demand for our services.
In recent years, members of Congress have introduced legislation, some of which has been the subject of hearings or floor debate, that would subject cigarettes to various regulations under the Department of Health and Human Services or regulation under the Consumer Products Safety Act, establish anti-smoking educational campaigns or anti-smoking programs, or provide additional funding for governmental anti-smoking activities, further restrict the advertising of cigarettes, including requiring additional warnings on packages and in advertising, provide that the Federal Cigarette Labeling and Advertising Act and the Smoking Education Act could not be used as a defense against liability under state statutory or common law, allow state and local governments to restrict the sale and distribution of cigarettes, and eliminate or reduce the tax deductibility of tobacco product advertising. If any or all of the foregoing were to be implemented, our business, volume, results of operations, cash flows and financial condition could be materially adversely affected.
A number of foreign nations also have taken steps to restrict or prohibit cigarette advertising and promotion, to increase taxes on cigarettes and to discourage cigarette smoking. In some cases, such restrictions are more onerous than those in the United States. For example, advertising and promotion of cigarettes has been banned or severely restricted for a number of years in Australia, Canada, Finland, France, Italy, Singapore and other countries. Further, in May of 2003, the World Health Organization adopted a treaty, the Framework Convention for Tobacco Control, which requires signatory nations to enact legislation that would require, among other things, specific actions to prevent youth smoking; restrict or prohibit tobacco product marketing; inform the public about the health consequences of smoking and the benefits of quitting; regulate the content of tobacco products; impose new package warning requirements including the use of pictorial or graphic images; eliminate cigarette smuggling and counterfeit cigarettes; restrict smoking in public places; increase and harmonize cigarette excise taxes; abolish duty-free tobacco sales; and permit and encourage litigation against tobacco product manufacturers. The treaty will take effect after forty countries ratify it, and must be implemented by national laws in the ratifying nations.
Due to the present regulatory and legislative environment, a substantial risk exists that past growth trends in tobacco product sales may not continue and that existing sales may decline.
20
ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIALCONDITION AND RESULTS OF OPERATIONS (Continued)
Risks Relating to the Tobacco Industry (Continued)
We have been, and continue to be, subject to governmental investigations into, and litigation concerning, leaf tobacco industry buying practices.
The leaf tobacco industry, from time to time, has been the subject of government investigations regarding trade practices. For example, in 1998 we were the subject of an investigation by the Antitrust Division of the United States Department of Justice into certain buying practices alleged to have occurred in the industry. More recently, we have been a named defendant in theDeLoach, et al. v. Philip Morris Companies Inc., et al., antitrust class action litigation alleging a conspiracy to rig bids in the tobacco auction markets.
In addition, certain other, similar investigations are ongoing. In October 2001, the Directorate General for Competition (DGCOMP) of the European Commission (EC) began conducting an administrative investigation into certain tobacco buying and selling practices alleged to have occurred within the leaf tobacco industry in Spain and Italy. We believe that the DGCOMP may be conducting similar investigations in other countries. Our subsidiaries in Spain (Agroexpansion) and Italy (DIMON Italia) have been the subject of those investigations. Based on our understanding of the facts pertaining to the activities of Spanish and Italian tobacco processors, including Agroexpansion and DIMON Italia, respectively, we believe there have been infringements of EU law. We expect that administrative penalties will be assessed, and those penalties could be material to our earnings. However, we are not able to make an assessment of the amount of any such penalties at this time.
In September 2002, the Argentina National Commission for Defense of Competition (“NCDC”) began an administrative inquiry into the tobacco and cigarette industry in Argentina including our subsidiary, DIMON Argentina S.A.
Adverse determinations in these or similar proceedings may negatively impact our future results.
Risks Relating to Owning Our Stock
Anti-takeover provisions could discourage a takeover that you consider to be in your best interest or prevent the removal of our current directors and management.
We have adopted a number of provisions that could have anti-takeover effects or prevent the removal of our current directors and management. We have adopted a shareholder protection rights plan, commonly referred to as a poison pill. The rights plan is intended to deter an attempt to acquire our company in a manner or on terms not approved by our Board of Directors. The rights plan will not prevent an acquisition that is approved by our Board of Directors. See also Note N to the “Notes to Consolidated Financial Statements.”
Our Articles of Incorporation authorize the Board of Directors to determine the terms of up to 10 million shares of undesignated preferred stock and issue such stock without stockholder approval. The issuance of preferred stock could make it more difficult for a third party to acquire, or discourage a third party from acquiring, voting control of our company in order to remove our current directors and management. These provisions could make more difficult the removal of our current directors and management or a takeover of our company, even if the events would be beneficial to our stockholders. These provisions could also limit the price that investors might be willing to pay for our common stock.
21
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
STATEMENTS OF CONSOLIDATED INCOME AND COMPREHENSIVE INCOME
DIMON Incorporated and Subsidiaries
| | | | | | | | | | | | |
(in thousands, except per share data)
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
| | 2003
| | | 2002
| |
Sales and other operating revenues | | $ | 802,083 | | | $ | 1,197,467 | | | $ | 1,192,613 | |
Cost of goods and services sold | | | 696,627 | | | | 992,182 | | | | 994,239 | |
| |
|
|
| |
|
|
| |
|
|
|
Gross profit | | | 105,456 | | | | 205,285 | | | | 198,374 | |
Selling, administrative and general expenses | | | 88,109 | | | | 113,583 | | | | 107,734 | |
Restructuring and asset impairment charges | | | 22,539 | | | | — | | | | — | |
| |
|
|
| |
|
|
| |
|
|
|
Operating income (loss) | | | (5,192 | ) | | | 91,702 | | | | 90,640 | |
Interest expense | | | 32,167 | | | | 46,887 | | | | 47,877 | |
Interest income | | | 6,397 | | | | 2,910 | | | | 3,897 | |
Derivative financial instruments (income)/expense | | | (6,522 | ) | | | 12,409 | | | | 10,202 | |
| |
|
|
| |
|
|
| |
|
|
|
Income (loss) before income taxes | | | (24,440 | ) | | | 35,316 | | | | 36,458 | |
Income taxes (benefit) | | | (589 | ) | | | 9,064 | | | | 9,912 | |
| |
|
|
| |
|
|
| |
|
|
|
Income (loss) after income taxes | | | (23,851 | ) | | | 26,252 | | | | 26,546 | |
Equity in net income (loss) of investee companies | | | (480 | ) | | | 349 | | | | (345 | ) |
Minority interests (income) | | | (2,792 | ) | | | (228 | ) | | | (57 | ) |
| |
|
|
| |
|
|
| |
|
|
|
Income (loss) from continuing operations | | | (21,539 | ) | | | 26,829 | | | | 26,258 | |
Income (loss) from discontinued operations, net of tax | | | (11,329 | ) | | | (549 | ) | | | 1,218 | |
| |
|
|
| |
|
|
| |
|
|
|
Income (loss) before extraordinary item | | | (32,868 | ) | | | 26,280 | | | | 27,476 | |
Extraordinary item-Iraqi receivable recovery, net of $957 income tax | | | — | | | | 1,777 | | | | — | |
| |
|
|
| |
|
|
| |
|
|
|
NET INCOME (LOSS) | | $ | (32,868 | ) | | $ | 28,057 | | | $ | 27,476 | |
| |
|
|
| |
|
|
| |
|
|
|
Other Comprehensive Income (Loss): | | | | | | | | | | | | |
Net Income (Loss) | | $ | (32,868 | ) | | $ | 28,057 | | | $ | 27,476 | |
Equity Currency Conversion Adjustment | | | 3,226 | | | | 3,668 | | | | 637 | |
Additional Minimum Pension Liability Adjustment, net of tax $(495) in 2004, $(1,111) in 2003 and $(468) in 2002 | | | (834 | ) | | | (1,745 | ) | | | (736 | ) |
Reclassification of Derivative Financial Instruments into Earnings, net of tax $(167) in 2004, $202 in 2003 and $2,112 in 2002. | | | (365 | ) | | | 418 | | | | 4,192 | |
Derivative Financial Instruments Adjustment, net of tax $602 in 2003 | | | — | | | | 1,220 | | | | — | |
| |
|
|
| |
|
|
| |
|
|
|
TOTAL COMPREHENSIVE INCOME (LOSS) | | $ | (30,841 | ) | | $ | 31,618 | | | $ | 31,569 | |
| |
|
|
| |
|
|
| |
|
|
|
Basic Earnings (Loss) Per Share | | | | | | | | | | | | |
Income (loss) from continuing operations | | $ | (.48 | ) | | $ | .60 | | | $ | .59 | |
Income (loss) from discontinued operations | | | (.25 | ) | | | (.01 | ) | | | .03 | |
Extraordinary item – Iraqi receivable recovery | | | — | | | | .04 | | | | — | |
| |
|
|
| |
|
|
| |
|
|
|
Net Income (Loss) | | $ | (.73 | ) | | $ | .63 | | | $ | .62 | |
| |
|
|
| |
|
|
| |
|
|
|
Diluted Earnings (Loss) Per Share | | | | | | | | | | | | |
Income (loss) from continuing operation | | $ | (.48 | ) | | $ | .59 | | | $ | .58 | |
Income (loss) from discontinued operations | | | (.25 | ) | | | (.01 | ) | | | .03 | |
Extraordinary item – Iraqi receivable recovery | | | — | | | | .04 | | | | — | |
| |
|
|
| |
|
|
| |
|
|
|
Net Income (Loss) | | $ | (.73 | )* | | $ | .62 | * | | $ | .61 | * |
| |
|
|
| |
|
|
| |
|
|
|
See notes to consolidated financial statements
* | Assumed conversion of Convertible Debentures at the beginning of the period has an antidilutive effect on earnings (loss) per share. For the nine months ended March 31, 2004, all outstanding restricted stock and stock options are excluded because their inclusion would have an antidilutive effect on the loss per share. |
22
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
CONSOLIDATED BALANCE SHEET
DIMON Incorporated and Subsidiaries
| | | | | | | | |
(in thousands)
| | March 31, 2004
| | | June 30, 2003
| |
ASSETS | | | | | | | | |
Current assets | | | | | | | | |
Cash and cash equivalents | | $ | 18,819 | | | $ | 88,932 | |
Notes receivable | | | 5,658 | | | | 2,619 | |
Trade receivables (net of allowances of $1,892 in 2004 and $1,693 in 2003) | | | 192,744 | | | | 172,945 | |
Inventories: | | | | | | | | |
Tobacco | | | 425,365 | | | | 447,896 | |
Other | | | 46,029 | | | | 24,635 | |
Advances on purchases of tobacco | | | 85,228 | | | | 39,824 | |
Current deferred and recoverable income taxes | | | 14,179 | | | | 11,349 | |
Prepaid expenses and other assets | | | 27,127 | | | | 26,930 | |
Assets of discontinued operations | | | 50,424 | | | | 33,178 | |
| |
|
|
| |
|
|
|
Total current assets | | | 865,573 | | | | 848,308 | |
| |
|
|
| |
|
|
|
Investments and other assets | | | | | | | | |
Equity in net assets of investee companies | | | 829 | | | | 6,061 | |
Other investments | | | 2,699 | | | | 2,919 | |
Notes receivable | | | 3,004 | | | | 3,832 | |
Other | | | 25,257 | | | | 37,684 | |
| |
|
|
| |
|
|
|
| | | 31,789 | | | | 50,496 | |
| |
|
|
| |
|
|
|
Goodwill and intangible assets | | | | | | | | |
Goodwill | | | 151,772 | | | | 151,772 | |
Production and supply contracts | | | 10,479 | | | | 12,543 | |
Pension asset | | | 1,934 | | | | 1,946 | |
| |
|
|
| |
|
|
|
| | | 164,185 | | | | 166,261 | |
| |
|
|
| |
|
|
|
Property, plant and equipment | | | | | | | | |
Land | | | 19,228 | | | | 18,786 | |
Buildings | | | 188,362 | | | | 183,037 | |
Machinery and equipment | | | 201,732 | | | | 196,191 | |
Allowances for depreciation | | | (171,167 | ) | | | (153,831 | ) |
| |
|
|
| |
|
|
|
| | | 238,155 | | | | 244,183 | |
| |
|
|
| |
|
|
|
Deferred taxes and other deferred charges | | | 57,702 | | | | 43,904 | |
| |
|
|
| |
|
|
|
| | $ | 1,357,404 | | | $ | 1,353,152 | |
23
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
CONSOLIDATED BALANCE SHEET
DIMON Incorporated and Subsidiaries
| | | | | | | | | | | | |
(in thousands)
| | | | | | March 31, 2004
| | | June 30, 2003
| |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | |
Notes payable to banks | | | | | | $ | 243,655 | | | $ | 210,162 | |
Accounts payable: | | | | | | | | | | | | |
Trade | | | | | | | 42,563 | | | | 51,171 | |
Officers and employees | | | | | | | 5,028 | | | | 10,273 | |
Other | | | | | | | 18,266 | | | | 9,421 | |
Advances from customers | | | | | | | 77,092 | | | | 70,800 | |
Accrued expenses | | | | | | | 32,878 | | | | 28,239 | |
Income taxes | | | | | | | 12,412 | | | | 14,896 | |
Long-term debt current | | | | | | | 2,976 | | | | 1,225 | |
Liabilities of discontinued operations | | | | | | | 11,001 | | | | 8,331 | |
| | | | | |
|
|
| |
|
|
|
Total current liabilities | | | | | | | 445,871 | | | | 404,518 | |
| | | | | |
|
|
| |
|
|
|
Long-term debt | | | | | | | | | | | | |
Revolving Credit Notes and other | | | | | | | 11,883 | | | | 10,250 | |
Convertible Subordinated Debentures | | | | | | | 73,328 | | | | 73,328 | |
Senior Notes (net of fair value adjustment of $10,798 in 2004 and $16,319 in 2003) | | | | | | | 335,798 | | | | 341,319 | |
| | | | | |
|
|
| |
|
|
|
| | | | | | | 421,009 | | | | 424,897 | |
| | | | | |
|
|
| |
|
|
|
Deferred credits: | | | | | | | | | | | | |
Income taxes | | | | | | | 4,911 | | | | 3,937 | |
Compensation and other | | | | | | | 69,614 | | | | 64,149 | |
| | | | | |
|
|
| |
|
|
|
| | | | | | | 74,525 | | | | 68,086 | |
| | | | | |
|
|
| |
|
|
|
Minority interest in subsidiaries | | | | | | | 1,114 | | | | 1,078 | |
| | | | | |
|
|
| |
|
|
|
Commitments and contingencies | | | | | | | — | | | | — | |
| | 2004
| | 2003
| | | | | | |
Stockholders’ equity | | | | | | | | | | | | |
Preferred stock—no par value: | | | | | | | | | | | | |
Authorized shares | | 10,000 | | 10,000 | | | | | | | | |
Issued shares | | — | | — | | | — | | | | — | |
Common stock—no par value: | | | | | | | | | | | | |
Authorized shares | | 125,000 | | 125,000 | | | | | | | | |
Issued shares | | 45,162 | | 44,737 | | | 185,527 | | | | 183,361 | |
Unearned compensation – restricted stock | | | | | | | (873 | ) | | | — | |
Retained earnings | | | | | | | 236,896 | | | | 279,904 | |
Accumulated other comprehensive income | | | | | | | (6,665 | ) | | | (8,692 | ) |
| | | | | |
|
|
| |
|
|
|
| | | | | | | 414,885 | | | | 454,573 | |
| | | | | |
|
|
| |
|
|
|
| | | | | | $ | 1,357,404 | | | $ | 1,353,152 | |
See notes to consolidated financial statements
24
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
STATEMENT OF STOCKHOLDERS’ EQUITY
DIMON Incorporated and Subsidiaries
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | Accumulated Other Comprehensive Income
| | | | |
(in thousands, except per share amounts)
| | Common Stock
| | Unearned Compensation
| | | Retained Earnings
| | | Equity Currency Conversions
| | | Additional Minimum Pension Liability, Net of Tax
| | | Derivative Financial Instruments, Net of Tax
| | | Total Stockholders’ Equity
| |
Balance, June 30, 2001 | | $ | 182,284 | | $ | — | | | $ | 245,601 | | | $ | (10,874 | ) | | $ | (644 | ) | | $ | (4,828 | ) | | $ | 411,539 | |
Net income for the year | | | | | | | | | | 27,476 | | | | | | | | | | | | | | | | 27,476 | |
Cash dividends - $.20 per share | | | | | | | | | | (8,929 | ) | | | | | | | | | | | | | | | (8,929 | ) |
Issue of 65,000 shares of restricted stock | | | 484 | | | | | | | | | | | | | | | | | | | | | | | 484 | |
Conversion of foreign currency financial statements | | | | | | | | | | | | | | 637 | | | | | | | | | | | | 637 | |
Adjustment in the minimum pension liability | | | | | | | | | | | | | | | | | | (736 | ) | | | | | | | (736 | ) |
Reclassification of derivative financial instruments into earnings. | | | | | | | | | | | | | | | | | | | | | | 4,192 | | | | 4,192 | |
| |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Balance, June 30, 2002 | | $ | 182,768 | | $ | — | | | $ | 264,148 | | | $ | (10,237 | ) | | $ | (1,380 | ) | | $ | (636 | ) | | $ | 434,663 | |
Net income for the year | | | | | | | | | | 28,057 | | | | | | | | | | | | | | | | 28,057 | |
Cash dividends - $.275 per share | | | | | | | | | | (12,301 | ) | | | | | | | | | | | | | | | (12,301 | ) |
Issue of 82,000 shares of restricted stock | | | 512 | | | | | | | | | | | | | | | | | | | | | | | 512 | |
Exercise of employee stock options | | | 81 | | | | | | | | | | | | | | | | | | | | | | | 81 | |
Conversion of foreign currency financial statements | | | | | | | | | | | | | | 3,668 | | | | | | | | | | | | 3,668 | |
Adjustment in the minimum pension liability | | | | | | | | | | | | | | | | | | (1,745 | ) | | | | | | | (1,745 | ) |
Reclassification of derivative financial instruments into earnings. | | | | | | | | | | | | | | | | | | | | | | 418 | | | | 418 | |
Adjustment in derivative financial statements | | | | | | | | | | | | | | | | | | | | | | 1,220 | | | | 1,220 | |
| |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Balance, June 30, 2003 | | $ | 183,361 | | $ | — | | | $ | 279,904 | | | $ | (6,569 | ) | | $ | (3,125 | ) | | $ | 1,002 | | | $ | 454,573 | |
Net loss for the nine months | | | | | | | | | | (32,868 | ) | | | | | | | | | | | | | | | (32,868 | ) |
Cash dividends - $.225 per share | | | | | | | | | | (10,140 | ) | | | | | | | | | | | | | | | (10,140 | ) |
Issue of 187,750 shares of restricted stock | | | 1,305 | | | (1,305 | ) | | | | | | | | | | | | | | | | | | | — | |
Earned Compensation | | | | | | 432 | | | | | | | | | | | | | | | | | | | | 432 | |
Exercise of employee stock options | | | 861 | | | | | | | | | | | | | | | | | | | | | | | 861 | |
Conversion of foreign currency financial statements | | | | | | | | | | | | | | 3,226 | | | | | | | | | | | | 3,226 | |
Adjustment in the minimum pension liability | | | | | | | | | | | | | | | | | | (834 | ) | | | | | | | (834 | ) |
Reclassification of derivative financial instruments into earnings | | | | | | | | | | | | | | | | | | | | | | (365 | ) | | | (365 | ) |
| |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Balance, March 31, 2004 | | $ | 185,527 | | $ | (873 | ) | | $ | 236,896 | | | $ | (3,343 | ) | | $ | (3,959 | ) | | $ | 637 | | | $ | 414,885 | |
See notes to consolidated financial statements
25
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
STATEMENT OF CONSOLIDATED CASH FLOWS
DIMON Incorporated and Subsidiaries
| | | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
(in thousands)
| | | 2003
| | | 2002
| |
Operating activities | | | | | | | | | | | | |
Net Income (Loss) | | $ | (32,868 | ) | | $ | 28,057 | | | $ | 27,476 | |
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities: | | | | | | | | | | | | |
Net (income) loss from discontinued operations | | | 11,329 | | | | 549 | | | | (1,218 | ) |
Depreciation and amortization | | | 26,349 | | | | 34,513 | | | | 41,222 | |
Restructuring and asset impairment charges | | | 22,539 | | | | — | | | | — | |
Deferred items | | | (13,220 | ) | | | 2,776 | | | | 8,782 | |
Loss on foreign currency transactions | | | 1,737 | | | | 3,507 | | | | 4,411 | |
Gain on disposition of fixed assets | | | (1,097 | ) | | | (1,376 | ) | | | (896 | ) |
Bad debt expense | | | 216 | | | | 95 | | | | 477 | |
Decrease (increase) in accounts receivable | | | (16,013 | ) | | | (1,695 | ) | | | 8,038 | |
Minority interests (income) | | | (2,792 | ) | | | (228 | ) | | | (57 | ) |
Increase in inventories and advances on purchases of tobacco | | | (20,405 | ) | | | (44,949 | ) | | | (17,227 | ) |
Increase in current deferred and recoverable taxes | | | (2,860 | ) | | | (1,482 | ) | | | (4,856 | ) |
Decrease (increase) in prepaid expenses | | | 338 | | | | (9,128 | ) | | | (5,524 | ) |
Increase (decrease) in accounts payable and accrued expenses | | | (3,837 | ) | | | (7,277 | ) | | | 9,491 | |
Increase (decrease) in advances from customers | | | 4,662 | | | | 3,821 | | | | (9,212 | ) |
Increase (decrease) in income taxes | | | (2,401 | ) | | | 3,628 | | | | 1,588 | |
Other | | | (561 | ) | | | 11 | | | | 418 | |
| |
|
|
| |
|
|
| |
|
|
|
Net cash provided (used) by operating activities of continuing operations | | | (28,884 | ) | | | 10,822 | | | | 62,913 | |
| |
|
|
| |
|
|
| |
|
|
|
Net cash provided (used) by operating activities of discontinued operations | | | (25,905 | ) | | | (3,271 | ) | | | 2,157 | |
| |
|
|
| |
|
|
| |
|
|
|
Net cash provided (used) by operating activities | | | (54,789 | ) | | | 7,551 | | | | 65,070 | |
| |
|
|
| |
|
|
| |
|
|
|
Investing activities | | | | | | | | | | | | |
Purchase of property and equipment | | | (25,743 | ) | | | (28,042 | ) | | | (19,701 | ) |
Proceeds from sale of property and equipment | | | 1,415 | | | | 2,746 | | | | 5,890 | |
Payments received on notes receivable | | | 1,633 | | | | 5,425 | | | | 5,442 | |
Issuance of notes receivable | | | (5,335 | ) | | | (2,027 | ) | | | (1,884 | ) |
Purchase of equity in subsidiaries and investees | | | (1,547 | ) | | | (9,090 | ) | | | — | |
Other | | | 1,419 | | | | (222 | ) | | | (199 | ) |
| |
|
|
| |
|
|
| |
|
|
|
Net cash used by investing activities | | | (28,158 | ) | | | (31,210 | ) | | | (10,452 | ) |
| |
|
|
| |
|
|
| |
|
|
|
26
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
STATEMENT OF CONSOLIDATED CASH FLOWS(Continued)
DIMON Incorporated and Subsidiaries
| | | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
(in thousands)
| | | 2003
| | | 2002
| |
Financing activities | | | | | | | | | | | | |
Net change in short-term borrowings | | $ | 25,459 | | | $ | 18,627 | | | $ | (30,129 | ) |
Proceeds from long-term borrowings | | | 42,126 | | | | 130,087 | | | | 266,253 | |
Repayment of long-term borrowings | | | (43,113 | ) | | | (131,356 | ) | | | (183,251 | ) |
Debt issuance cost | | | (1,525 | ) | | | (2,631 | ) | | | (7,566 | ) |
Proceeds from sale of stock | | | 705 | | | | — | | | | — | |
Cash dividends paid to DIMON Incorporated stockholders | | | (10,140 | ) | | | (12,301 | ) | | | (8,929 | ) |
| |
|
|
| |
|
|
| |
|
|
|
Net cash provided by financing activities | | | 13,512 | | | | 2,426 | | | | 36,378 | |
| |
|
|
| |
|
|
| |
|
|
|
Effect of exchange rate changes on cash | | | (678 | ) | | | 1,174 | | | | 3,401 | |
| | | |
Increase (decrease) in cash and cash equivalents | | | (70,113 | ) | | | (20,059 | ) | | | 94,397 | |
Cash and cash equivalents at beginning of year | | | 88,932 | | | | 108,991 | | | | 14,594 | |
| |
|
|
| |
|
|
| |
|
|
|
Cash and cash equivalents at end of year | | $ | 18,819 | | | $ | 88,932 | | | $ | 108,991 | |
| |
|
|
| |
|
|
| |
|
|
|
Other information: | | | | | | | | | | | | |
Cash paid during the year: | | | | | | | | | | | | |
Interest | | $ | 27,315 | | | $ | 48,502 | | | $ | 42,049 | |
Income taxes | | | 14,165 | | | | 16,674 | | | | 12,301 | |
See notes to consolidated financial statements
27
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DIMON Incorporated and Subsidiaries
(in thousands)
Note A – Significant Accounting Policies
Basis of Presentation
The accounts of the Company and its consolidated subsidiaries are included in the consolidated financial statements after elimination of significant intercompany accounts and transactions. The Company uses the equity method of accounting for its investments in affiliates, which are owned 50% or less.
All periods including quarterly information presented in the financial statements have been restated to reflect the Company’s sale of its Italian processing facility and simultaneous decision to discontinue its Italian operations as discussed in Note B to the “Notes to Consolidated Financial Statements.”
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates, and changes in these estimates are recorded when known. Estimates are used in accounting for, among other things, pension and postretirement health care benefits, inventory market values, allowance for doubtful accounts, useful lives for depreciation and amortization, future cash flows associated with impairment testing for goodwill and long-lived assets and for determining the primary beneficiary of variable interest entities, deferred tax assets and potential income tax assessments, and contingencies.
Revenue Recognition
The Company recognizes revenue when persuasive evidence of an arrangement exists, the price to the customer is fixed, collectibility is reasonably assured and title and risk of ownership is passed to the customer, which is usually upon shipment. However, certain customers traditionally have requested to take title and risk of ownership prior to shipment. Revenue for these transactions is recognized only when:
| (1) | Title and risk of ownership have passed to the customer; |
| (2) | The Company has obtained a written fixed purchase commitment; |
| (3) | The customer has requested the transaction be on a bill and hold basis; |
| (4) | The customer has provided a delivery schedule; |
| (5) | All performance obligations related to the sale have been completed; |
| (6) | The tobacco has been processed to the customer’s specifications, accepted by the customer and made ready for shipment; and |
| (7) | The tobacco is segregated and is not available to fill other orders. |
The remittance terms for these “bill and hold” transactions are consistent with all other sales by the Company.
The Company also processes tobacco owned by its customers, and revenue is recognized when the processing is completed.
Shipping and Handling
Shipping and handling costs are included in cost of goods and services sold in the Statement of Consolidated Income.
Cash and Cash Equivalents
Cash equivalents are defined as temporary investments of cash with maturities of less than 90 days.
28
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DIMON Incorporated and Subsidiaries
(in thousands)
Note A – Significant Accounting Policies (Continued)
Inventories
Inventories are valued at the lower of cost or market. Inventories are reviewed and adjusted for changes in market value based on assumptions related to future demand and worldwide and local market conditions. If actual demand and market conditions vary from those projected by management, adjustments to lower of cost or market value may be required. Inventory write downs as of March 31, 2004 and June 30, 2003 were $5,043 and $3,070, respectively.
Costs of tobacco inventories are generally determined by the average cost method while costs of other inventories are generally determined by the first-in, first-out method. Costs included in tobacco inventory include both the cost of raw material as well as direct and indirect costs that are related to the processing of the product. Tobacco inventory is substantially finished goods. Costs included in other inventories are costs of spare parts, packing materials, non-tobacco agricultural products and agricultural supplies including seed, fertilizer, herbicides and pesticides. Interest and other carrying charges on the inventories are expensed in the period in which they are incurred.
Goodwill and Other Intangibles
Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses. Goodwill is not subject to systematic amortization, but rather is tested for impairment annually and whenever events and circumstances indicate that an impairment may have occurred. Impairment testing compares the carrying amount of the goodwill with its fair value. Fair value is estimated based on discounted cash flows. When the carrying amount of goodwill exceeds its fair value, an impairment charge would be recorded. The Company has chosen the first day of the last quarter of its fiscal year as the date to perform its annual goodwill impairment test. The Company found no indication of impairment at that date. Subsequent to this review, the Company acquired majority interest in an entity previously reported using the equity method of accounting. Due to indicators of impairment at March 31, 2004, the goodwill associated with this investment was reviewed and found to be impaired. The Company recorded a pre-tax charge of $5,439 during fiscal 2004 related to goodwill impairment. See Note C to the “Notes to Consolidated Financial Statements” for further disclosure on goodwill impairment. Impairment losses are reflected in operating income in the statement of operations.
The Company has no intangible assets with indefinite useful lives. It does have other intangible assets, production and supply contracts, with carrying values of $10,479 and $12,543 as of March 31, 2004 and June 30, 2003, net of accumulated amortization of $8,209 and $6,130, respectively. Supply contracts are amortized primarily on a straight-line basis over the term of the contract ranging from three to five years. Production contracts are amortized on a straight-line basis ranging from five to ten years. The amortization period is the term of the contract or, if no term is specified in the contract, management’s best estimate of the useful life based on past experience. The Company reviews the estimated useful lives of its intangibles at the end of each reporting period. If events and circumstances warrant a change in the estimated useful life, the remaining carrying amount will be amortized over the revised estimated useful life. Amortization expense associated with these intangible assets was $1,967, $1,609 and $3,197 for the nine months ended March 31, 2004 and years ended June 30, 2003 and 2002, respectively. Annual amortization expense for each of the next five years for these production and supply contracts is expected to be $2,636 in 2005; $2,446 in 2006; $2,069 in 2007; $1,274 in 2008 and $701 in 2009.
In accordance with the requirements of SFAS No. 142, the Company discontinued the amortization of goodwill. The following pro forma disclosure presents net income and net income per share as if the goodwill requirements of SFAS No. 142 had been adopted as of July 1, 2001.
| | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
|
(in thousands, except per share data) | | | 2003
| | 2002
|
Reported net income (loss) | | $ | (32,868 | ) | | $ | 28,057 | | $ | 27,476 |
Amortization of goodwill (net of $41 tax for 2002) | | | — | | | | — | �� | | 6,497 |
| |
|
|
| |
|
| |
|
|
Adjusted net income (loss) | | $ | (32,868 | ) | | $ | 28,057 | | $ | 33,973 |
| |
|
|
| |
|
| |
|
|
Reported basic earnings (loss) per share | | $ | (0.73 | ) | | $ | 0.63 | | $ | 0.62 |
Amortization of goodwill (net of tax) | | | — | | | | — | | | 0.14 |
| |
|
|
| |
|
| |
|
|
Adjusted basic earnings (loss) per share | | $ | (0.73 | ) | | $ | 0.63 | | $ | 0.76 |
| |
|
|
| |
|
| |
|
|
29
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DIMON Incorporated and Subsidiaries
(in thousands)
Note A – Significant Accounting Policies (Continued)
Property and Depreciation
Property, plant and equipment is accounted for on the basis of cost. Provisions for depreciation are computed on a straight-line basis at annual rates calculated to amortize the cost of depreciable properties over their estimated useful lives. Buildings, machinery and equipment and technological equipment are depreciated over ranges of 20 to 40 years, 5 to 10 years and 3 to 5 years, respectively. The consolidated financial statements do not include fully depreciated assets. Depreciation expense for the nine months ended March 31, 2004 and fiscal years 2003 and 2002 was $22,870, $30,342 and $29,012, respectively.
Estimated useful lives are periodically reviewed and, when warranted, changes are made to the estimated useful lives. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their cost may not be recoverable. An impairment loss would be recognized when estimated undiscounted future cash flows from the use of the asset and its eventual disposition are less than its carrying amount. Measurement of an impairment loss would be based on the excess of the carrying amount of the asset over its fair value. Fair value is the amount at which the asset could be bought or sold in a current transaction between willing parties and may be estimated using a number of techniques, including quoted market prices or valuations by third parties, present value techniques based on estimates of cash flows, or multiples of earnings or revenue performance measures. See Note C to the “Notes to Consolidated Financial Statements” for further disclosure of asset impairment.
Income Taxes
The Company accounts for income taxes in accordance with SFAS No. 109, “Accounting for Income Taxes.” Under SFAS No. 109, deferred tax assets and liabilities are determined based on the difference between the financial statements and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.
Accounting Pronouncements
In May 2003, FASB issued SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” Under the provisions of SFAS No. 150 certain financial instruments that previously could be accounted for as equity must be presented as liabilities, and in some cases assets, on the balance sheet. The Company adopted this new standard July 1, 2003 and it did not have a material effect on its financial statements.
In December 2003, the FASB issued a revised Interpretation No. 46, Consolidation of Variable Interest Entities (“FIN 46R”). FIN 46R requires a new approach in determining if a reporting entity consolidates certain legal entities referred to as variable interests entities (“VIEs”), including joint ventures, limited liability companies and equity investments. A VIE is an entity in which the equity investors do not have a controlling interest or have insufficient resources to finance the entity’s activities without receiving additional financial support from the other parties. Under FIN 46R, consolidation of a VIE is required by the investor with the majority of the variable interests in the entity. The revised interpretation delays the effective date to periods ending after December 15, 2003 for special purpose entities and to periods ending after March 15, 2004 for all other types of VIE’s. The adoption of the revised FIN 46R did not have a material effect on the Company’s financial position or results of operations.
In December 2003, the FASB issued a revision to FASB Statement No. 132 – Employers’ Disclosures about Pensions and Other Postretirement Benefits (“FASB No. 132R”). The revision expands disclosures for defined benefit plans and other postretirement plans in both annual and interim financial statements. The effective date for FASB No. 132R is for fiscal years ending after December 15, 2003. Interim period disclosure is required for interim periods beginning after December 15, 2003. The Company adopted the additional annual disclosure requirements as of the fiscal year ending March 31, 2004.
30
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note A – Significant Accounting Policies (Continued)
DIMON and Subsidiaries Computation of Earnings Per Common Share
| | | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
(in thousands, except per share data)
| | | 2003
| | | 2002
| |
BASIC EARNINGS | | | | | | | | | | | | |
Income (loss) from continuing operations | | $ | (21,539 | ) | | $ | 26,829 | | | $ | 26,258 | |
Income (loss) from discontinued operations | | | (11,329 | ) | | | (549 | ) | | | 1,218 | |
Extraordinary item: Iraqi receivable recovery | | | — | | | | 1,777 | | | | — | |
| |
|
|
| |
|
|
| |
|
|
|
Net Income (Loss) | | $ | (32,868 | ) | | $ | 28,057 | | | $ | 27,476 | |
| |
|
|
| |
|
|
| |
|
|
|
SHARES | | | | | | | | | | | | |
Weighted Average Number of Shares Outstanding | | | 44,723 | | | | 44,532 | | | | 44,525 | |
| |
|
|
| |
|
|
| |
|
|
|
BASIC EARNINGS (LOSS) PER SHARE | | | | | | | | | | | | |
Income (loss) from continuing operations | | $ | (.48 | ) | | $ | .60 | | | $ | .59 | |
Income (loss) from discontinued operations | | | (.25 | ) | | | (.01 | ) | | | .03 | |
Extraordinary item – Iraqi receivable recovery | | | — | | | | .04 | | | | — | |
| |
|
|
| |
|
|
| |
|
|
|
Net Income (Loss) | | $ | (.73 | ) | | $ | .63 | | | $ | .62 | |
| |
|
|
| |
|
|
| |
|
|
|
DILUTED EARNINGS | | | | | | | | | | | | |
Income (loss) from continuing operations | | $ | (21,539 | ) | | $ | 26,829 | | | $ | 26,258 | |
Add after tax interest expense applicable to 6 1/4% Convertible Debentures issued April 1, 1997 | | | — | * | | | — | * | | | — | * |
| |
|
|
| |
|
|
| |
|
|
|
Income (loss) from continuing operations | | | (21,539 | ) | | | 26,829 | | | | 26,258 | |
Income (loss) from discontinued operations | | | (11,329 | ) | | | (549 | ) | | | 1,218 | |
Extraordinary item: Iraqi receivable recovery | | | — | | | | 1,777 | | | | — | |
| |
|
|
| |
|
|
| |
|
|
|
Net Income (Loss) as Adjusted | | $ | (32,868 | )* | | $ | 28,057 | * | | $ | 27,476 | * |
| |
|
|
| |
|
|
| |
|
|
|
SHARES | | | | | | | | | | | | |
Weighted average number of common shares outstanding | | | 44,723 | | | | 44,532 | | | | 44,525 | |
Restricted shares issued and shares applicable to stock options, net of shares assumed to be purchased from proceeds at average market price | | | — | * | | | 534 | | | | 522 | |
Assuming conversion of 6 1/4% Convertible Debentures at the beginning of the period | | | — | * | | | — | * | | | — | * |
| |
|
|
| |
|
|
| |
|
|
|
Average Number of Shares Outstanding | | | 44,723 | * | | | 45,066 | * | | | 45,047 | * |
| |
|
|
| |
|
|
| |
|
|
|
DILUTED EARNINGS (LOSS) PER SHARE | | | | | | | | | | | | |
Income (loss) from continuing operations | | $ | (.48 | ) | | $ | .59 | | | $ | .58 | |
Income (loss) from discontinued operations | | $ | (.25 | ) | | $ | (.01 | ) | | | .03 | |
Extraordinary item – Iraqi receivable recovery | | | — | | | | .04 | | | | — | |
| |
|
|
| |
|
|
| |
|
|
|
Net Income (Loss) as Adjusted | | $ | (.73 | )* | | $ | .62 | * | | $ | .61 | * |
| |
|
|
| |
|
|
| |
|
|
|
* | Assumed conversion of Convertible Debentures at the beginning of the period has an antidilutive effect on earnings (loss) per share. For the nine months ended March 31, 2004, all outstanding restricted stock and stock options are excluded because their inclusion would have an antidilutive effect on the loss per share. |
31
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note A – Significant Accounting Policies (Continued)
Stock-Based Compensation
The Company’s stock option plans are described more fully in Note J to the “Notes to Consolidated Financial Statements.” The Company accounts for its plans under the recognition and measurement principles of APB Opinion No. 25, “Accounting for Stock Issued to Employees” and related Interpretations. No stock-based employee compensation cost is reflected in net income, as all options granted under these plans had an exercise price equal to the market value of the underlying common stock on the date of grant. Net income, as reported, includes compensation expense related to restricted stock. The following table illustrates the effect on net income (loss) and earnings (loss) per share if the Company had applied the fair value recognition provisions of SFAS No. 123, “Accounting for Stock-Based Compensation,” to stock-based employee compensation.
| | | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
(in thousands, except per share data)
| | | 2003
| | | 2002
| |
Net income (loss), as reported | | $ | (32,868 | ) | | $ | 28,057 | | | $ | 27,476 | |
Add: Stock-based employee compensation expense (income) included in reported net income (loss), net of related tax effects | | | (200 | ) | | | 176 | | | | (142 | ) |
Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects | | | (1,192 | ) | | | (1,211 | ) | | | (600 | ) |
| |
|
|
| |
|
|
| |
|
|
|
Pro forma net income (loss) | | $ | (34,260 | ) | | $ | 27,022 | | | $ | 26,734 | |
| |
|
|
| |
|
|
| |
|
|
|
Earnings (loss) per share: | | | | | | | | | | | | |
Basic – as reported | | $ | (0.73 | ) | | $ | 0.63 | | | $ | 0.62 | |
Basic – pro forma | | $ | (0.77 | ) | | $ | 0.61 | | | $ | 0.60 | |
| |
|
|
| |
|
|
| |
|
|
|
Diluted – as reported | | $ | (0.73 | ) | | $ | 0.62 | | | $ | 0.61 | |
Diluted – pro forma | | $ | (0.77 | ) | | $ | 0.60 | | | $ | 0.59 | |
| |
|
|
| |
|
|
| |
|
|
|
Related Parties
During the nine months ended March 31, 2004, and fiscal years 2003 and 2002, the Company paid $2,029, $3,382 and $2,741, respectively, in leasing arrangements for storage facilities and equipment. The primary owners of the lessor are current and former employees of a subsidiary of the Company in Zimbabwe.
Reclassifications
Certain prior year amounts have been reclassified to conform to the current year presentation.
32
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note A – Significant Accounting Policies (Continued)
Change in Fiscal Year
On June 23, 2003, our Board of Directors adopted a change in fiscal year end from June 30 to March 31. The primary purpose of the change is to better match the financial reporting cycle with natural global crop cycles for leaf tobacco. As a result of this change, the Company has a nine month transition period ended March 31, 2004. The Company’s new fiscal year 2005 began on April 1, 2004. Condensed consolidated comparative financial data for the nine months ended March 31, 2004 and 2003, are summarized below:
| | | | | | | | |
(in thousands)
| | Nine Months Ended March 31, 2004
| | | Nine Months Ended March 31, 2003 (unaudited)
| |
Sales and other operating revenues | | $ | 802,083 | | | $ | 849,247 | |
Gross profit | | | 105,456 | | | | 136,726 | |
Selling, administrative and general expenses | | | 88,109 | | | | 76,331 | |
Restructuring and asset impairment charges | | | 22,539 | | | | — | |
Interest expense | | | 32,167 | | | | 34,268 | |
Interest income | | | 6,397 | | | | 2,436 | |
Derivative financial instruments (income) expense | | | (6,522 | ) | | | 10,371 | |
Income taxes (benefit) | | | (589 | ) | | | 4,091 | |
Equity in net income (loss) of investee companies | | | (480 | ) | | | (171 | ) |
Minority interests (income) | | | (2,792 | ) | | | 55 | |
| |
|
|
| |
|
|
|
Income (loss) from continuing operations | | | (21,539 | ) | | | 13,875 | |
Income (loss) from discontinued operations | | | (11,329 | ) | | | 125 | |
| |
|
|
| |
|
|
|
NET INCOME (LOSS) | | $ | (32,868 | ) | | $ | 14,000 | |
| |
|
|
| |
|
|
|
Earnings (loss) per share: | | | | | | | | |
Basic | | | | | | | | |
Income (loss) from continuing operations | | $ | (0.48 | ) | | $ | 0.31 | |
Income (loss) from discontinued operations | | $ | (0.25 | ) | | | — | |
| |
|
|
| |
|
|
|
Net Income (loss) | | $ | (0.73 | ) | | $ | 0.31 | |
| |
|
|
| |
|
|
|
Diluted | | | | | | | | |
Income (loss) from continuing operations | | $ | (0.48 | ) | | $ | 0.31 | |
Income (loss) from discontinued operations | | $ | (0.25 | ) | | | — | |
| |
|
|
| |
|
|
|
Net Income (loss) | | $ | (0.73 | ) | | $ | 0.31 | |
| |
|
|
| |
|
|
|
Note B –Discontinued Operations
The Company conducted a strategic review in the third quarter of fiscal 2004 to evaluate its production capacity and organization relative to the major transition occurring in global sourcing of tobacco. As a result of the review, the Company’s Board of Directors approved a plan (the “Plan”) designed to improve long-term profitability. One of the major initiatives approved in the Plan was the disposal of the Company’s Italian processing facility.
SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. As a result of the Plan, the fixed assets of the Italian processing facility were determined to be impaired based upon future undiscounted cash flows being insufficient to support their carrying value. At March 31, 2004, a pre-tax (and after-tax) impairment charge of $6,941 on fixed assets, primarily machinery and equipment, was recorded based on fair values determined by subsequent asset disposal agreements.
33
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note B –Discontinued Operations(Continued)
On September 30, 2004, concurrent with the sale of the Italian processing facility, the Company made a decision to discontinue all Italian operations as part of its ongoing plans to realign its operations to more closely reflect worldwide changes in the sourcing of tobacco. The Company expects to exit the Italian market completely by September 30, 2005.
Results of operations and the assets and liabilities, other than subsidiary debt guaranteed by the Company and related interest expense, have been reclassified and presented as discontinued operations in the financial statements and related notes for all periods presented herein. Sales and operating losses for the fiscal years ended June 30, 2002 and 2003 and the nine month transition year ended March 31, 2004 are presented below. In addition to the operating losses, an estimated loss on disposal was recorded during the nine month transition year ended March 31, 2004. This information is summarized for the appropriate fiscal periods as follows:
| | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
|
| | | 2003
| | | 2002
|
Sales and other revenues | | $ | 15,309 | | | $ | 32,826 | | | $ | 29,298 |
| |
|
|
| |
|
|
| |
|
|
Income (loss) from discontinued operations, net of tax: | | | | | | | | | | | |
Income (loss) from operations of discontinued components | | $ | (4,450 | ) | | $ | (502 | ) | | $ | 1,508 |
Loss on disposal of discontinued components | | | (6,941 | ) | | | — | | | | — |
| |
|
|
| |
|
|
| |
|
|
Income (loss) from discontinued operations, before tax | | | (11,391 | ) | | | (502 | ) | | | 1,508 |
Income tax expense / (benefit) | | | (62 | ) | | | 47 | | | | 290 |
| |
|
|
| |
|
|
| |
|
|
Income (loss) from discontinued operations, net of tax | | $ | (11,329 | ) | | $ | (549 | ) | | $ | 1,218 |
| |
|
|
| |
|
|
| |
|
|
| | | | | | |
| | March 31, 2004
| | June 30, 2003
|
Assets of discontinued operations: | | | | | | |
Trade receivables, net of allowances | | $ | 5,414 | | $ | 6,587 |
Tobacco inventory and advances | | | 42,304 | | | 17,501 |
Net property, plant and equipment | | | 1,953 | | | 8,312 |
Other assets | | | 753 | | | 778 |
| |
|
| |
|
|
Total assets of discontinued operations | | $ | 50,424 | | $ | 33,178 |
| |
|
| |
|
|
Liabilities of discontinued operations: | | | | | | |
Accounts payable | | $ | 6,707 | | $ | 2,651 |
Advances from customers | | | 2,814 | | | 4,319 |
Deferred Credits – Compensation and other | | | 1,077 | | | 1,103 |
Other liabilities | | | 403 | | | 258 |
| |
|
| |
|
|
Total liabilities of discontinued operations | | $ | 11,001 | | $ | 8,331 |
| |
|
| |
|
|
Note C – Restructuring and Asset Impairment Charges
The Company conducted a strategic review in the third quarter of 2004 to compare its production capacity and organization with the major transition occurring in global sourcing of tobacco. As a result, the Company’s Board of Directors recently approved a Plan designed to improve long-term profitability. Major initiatives approved in the Plan include the closing of one of its two U.S. processing facilities and disposal of its non-strategic processing facility in Italy.
34
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note C – Restructuring and Asset Impairment Charges(Continued)
SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Based upon diminished U.S. crop production and processing requirements, the Board of Directors approved the closing of one of its U.S. processing facilities upon completion of the processing of the 2004 U.S. crop. As a result of the approved Plan, the related U.S. and European fixed assets are determined to be impaired based upon future undiscounted cash flows being insufficient to support their carrying value. A pre-tax impairment charge of $9,811 on fixed assets, primarily machinery and equipment, was recorded based on asset fair values as determined by independent appraisals or subsequent asset disposal agreements. In addition, a $1,682 pre-tax charge for severance and other costs was recorded for employees notified prior to year end. Substantially all severance costs will be paid in fiscal 2005. Additional severance charges associated with this initiative will be incurred during fiscal 2005 as employees are notified.
In Zimbabwe, the Company recorded a pre-tax asset impairment charge of $4,905 related to land and buildings no longer used in operations. The forecasted undiscounted cash flows of these assets, which are leased to a third party, did not support the carrying value and the assets were written down to their appraised fair value.
During January 2004, the Company acquired a majority interest in a non-tobacco entity previously reported using the equity method of accounting. Production expectations and the development of emerging markets have not met management’s expectations. Management completed an impairment evaluation based on projected future cash flows in the March quarter as indicators of impairment were present and determined that the carrying value of the assets exceeded their fair values. The Company recorded a pre-tax impairment charge of $702 related to fixed assets and $5,439 related to goodwill based on asset fair values as determined by independent appraisals.
The following table summarizes the restructuring and asset impairment costs recorded as of March 31, 2004:
| | | | | | | | | | |
| | Asset Impairments
| | | Employee Separation and Other Costs
| | Total Restructuring and Asset Impairment Charges
|
2004 Restructuring and Asset Impairment Charges: | | | | | | | | | | |
Third Quarter | | $ | 20,857 | * | | $ | 1,682 | | $ | 22,539 |
| |
|
|
| |
|
| |
|
|
* | Includes pretax charges of $15,418 and $5,439 for fixed asset and goodwill impairments, respectively. |
Note D – Foreign Currency Translation
The financial statements of foreign entities included in the consolidated financial statements have been translated to U.S. dollars in accordance with SFAS No. 52, “Foreign Currency Translation.”
The financial statements of foreign subsidiaries, for which the local currency is the functional currency, are translated into U.S. dollars using exchange rates in effect at period end for assets and liabilities and average exchange rates during each reporting period for results of operations. Adjustments resulting from translation of financial statements are reflected as a separate component of other comprehensive income.
The financial statements of foreign subsidiaries, for which the U.S. dollar is the functional currency and which have certain transactions denominated in a local currency, are remeasured into U.S. dollars. The remeasurement of local currencies into U.S. dollars creates remeasurement adjustments that are included in net income. Exchange losses in 2004, 2003 and 2002 were $1,705, $3,666 and $4,486, respectively and are included in the respective statements of income.
35
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note E – Derivative and Other Financial Instruments
Fair Value of Derivative Financial Instruments
In accordance with SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” the Company recognizes all derivative financial instruments, such as interest rate swap contracts and foreign exchange contracts, in the consolidated financial statements at fair value regardless of the purpose or intent for holding the instrument. Changes in the fair value of derivative financial instruments are either recognized periodically in income or in shareholders’ equity as a component of comprehensive income depending on whether the derivative financial instrument qualifies for hedge accounting, and if so, whether it qualifies as a fair value hedge or cash flow hedge. Changes in fair values of derivatives accounted for as fair value hedges are recorded in income along with the portions of the changes in the fair values of the hedged items that relate to the hedged risk(s). Changes in fair values of derivatives accounted for as cash flow hedges, to the extent they are effective as hedges, are recorded in other comprehensive income net of deferred taxes. Changes in fair values of derivatives not qualifying as hedges are reported in income.
The fair value estimates presented herein are based on quoted market prices.
During the nine months ended March 31, 2004, accumulated other comprehensive income decreased by $365, net of deferred taxes of $167 due to the reclassification into earnings, primarily as cost of goods and services sold, due to the fulfillment of transactions. During the fiscal year ended June 30, 2003, accumulated other comprehensive income increased by $1,638, net of deferred taxes of $804, due to the reclassification of $418, net of taxes of $202, which was reclassified into earnings, primarily as cost of goods and services sold, due to the fulfillment of transactions. The remaining $1,220, net of tax of $602, was due to the issuance of new cash flow hedges during the year. During the fiscal year ended June 30, 2002, accumulated other comprehensive income decreased by $4,192, net of deferred taxes of $2,112, due to the reclassification of net losses on derivative instruments to earnings. Of this amount, $994, net of taxes of $535, was reclassified into earnings as a result of the discontinuance of a cash flow hedge that had been deemed effective.
At March 31, 2004, the Company expects to reclassify approximately $637 of gains on derivative instruments, net of deferred taxes of $324, from accumulated other comprehensive income to earnings during the next twelve months due to the actual fulfillment of forecasted transactions. The Company is hedging its exposure to the variability of future cash flows for forecasted transactions over various time periods not exceeding ten years.
The carrying value and estimated fair value of the Company’s long-term debt are $423,985 and $436,766, respectively, as of March 31, 2004 and $426,122 and $449,522, respectively, as of June 30, 2003.
Fixed to Floating Rate Interest Swaps
Concurrent with the private issuance of $200 million principal amount of 9 5/8% Senior Notes on October 30, 2001, the Company entered into a derivative financial instrument to swap the entire $200 million notional amount of the Senior Notes to a floating interest rate equal to LIBOR plus 4.11%, set six months in arrears. Also, concurrent with the private issuance of $125 million principal amount of 7 3/4% Senior Notes on May 30, 2003, the Company entered into a derivative financial instrument to swap the entire $125 million notional amount of Senior Notes to a floating interest rate equal to LIBOR plus 3.69%, set six months in arrears. See also Note F to the “Notes to Consolidated Financial Statements.”
The maturity, payment dates, and other fundamental terms of these derivative financial instruments match those of the related Senior Notes. In accordance with SFAS No. 133, these derivatives qualify for hedge accounting treatment. They are accounted for as fair value hedges. Changes in the fair value of these derivative financial instruments, as well as offsetting changes in the fair value of the Senior Notes, are being recognized in current period earnings. As of March 31, 2004 and June 30, 2003, the fair value of the debt increased the Senior Notes liability by $10,798 and $16,319, respectively, with a corresponding change in the fair value of the derivative financial instruments reflected in Deferred Credits – Compensation and Other.
36
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note E – Derivative and Other Financial Instruments(Continued)
Floating to Fixed Rate Interest Swaps
Prior to the implementation of SFAS No. 133, the Company entered into multiple interest swaps to convert a portion of its worldwide debt portfolio from floating to fixed interest rates, to reduce its exposure to interest rate volatility. At March 31, 2004, the Company held instruments of this type with an aggregate notional value of $245,000, bearing interest at rates between 4.985% and 6.22%, and with maturity dates ranging from August 23, 2005 to September 22, 2008. The implementation of SFAS No. 133 eliminated hedge accounting treatment for these instruments because they do not meet certain criteria. Accordingly, the Company is required to reflect the full amount of all changes in their fair value, without offset, in its current earnings. These fair value adjustments have caused substantial volatility in the Company’s reported earnings. For the nine months ended March 31, 2004, the Company recognized non-cash income before income taxes of $6,522 from the change in fair value of these derivative financial instruments. For the fiscal years ended June 30, 2003 and 2002, the Company recognized non-cash expense before income taxes of $12,409 and $10,202, respectively, from the change in the fair value of these derivative financial instruments. With the recognition of each income or expense relating to these instruments, a corresponding amount is recognized in Deferred Credits – Compensation and Other. At March 31, 2004, there was an aggregate credit of $21,363 relating to these instruments accumulated in this balance sheet classification, all of which will reverse through future earnings over the remaining life of the instruments.
Forward Currency Contracts
The Company periodically enters into forward currency contracts to protect against volatility associated with certain non-U.S. dollar denominated forecasted transactions. In accordance with SFAS No. 133, these derivatives qualify for hedge accounting treatment. They are accounted for as a cash flow hedges. Changes in the fair value of these derivative financial instruments, net of deferred taxes, are recognized in Other Comprehensive Income and are included in earnings in the period in which earnings are affected by the hedged item.
Credit Risk
Financial instruments, including derivatives, expose the Company to credit loss in the event of non-performance by counterparties. The Company manages its exposure to counterparty credit risk through specific minimum credit standards, diversification of counterparties, and procedures to monitor concentrations of credit risk. If a counterparty fails to meet the terms of an arrangement, the Company’s exposure is limited to the net amount that would have been received, if any, over the arrangement’s remaining life. The Company does not anticipate non-performance by the counterparties and no material loss would be expected from non-performance by any one of such counterparties.
Note F – Short-Term Borrowing Arrangements
Excluding all long-term credit agreements, the Company has lines of credit arrangements with a number of banks under which the Company may borrow up to a total of $594,285 at March 31, 2004 ($480,394 at June 30, 2003). These lines bear interest at a weighted average rate of 2.99% for the nine months ending March 31, 2004. Unused lines of credit at March 31, 2004, amounted to $305,115 ($234,031 at June 30, 2003), net of $45,515 of available letters of credit lines. Certain non-U.S. borrowings of approximately $12,894 have inventories of approximately $18,707 as collateral. There were no compensating balance agreements at March 31, 2004 or June 30, 2003.
Note G – Long-Term Debt
Such debt is comprised of:
| | | | | | | | | | | | |
| | March 31, 2004
| | June 30, 2003
|
| | Maturing within One Year
| | Maturing after One Year
| | Maturing within One Year
| | Maturing after One Year
|
Senior Notes (Net of Fair Value Adjustment of $10,798 in 2004 and $16,319 in 2003) | | $ | — | | $ | 335,798 | | $ | — | | $ | 341,319 |
Convertible Subordinated Debentures | | | — | | | 73,328 | | | — | | | 73,328 |
Revolving Credit Notes | | | — | | | — | | | — | | | — |
Other Long-Term Debt | | | 2,411 | | | 8,146 | | | 655 | | | 6,076 |
| |
|
| |
|
| |
|
| |
|
|
| | | 2,411 | | | 417,272 | | | 655 | | | 420,723 |
Capitalized Lease Obligations | | | 565 | | | 3,737 | | | 570 | | | 4,174 |
| |
|
| |
|
| |
|
| |
|
|
| | $ | 2,976 | | $ | 421,009 | | $ | 1,225 | | $ | 424,897 |
| |
|
| |
|
| |
|
| |
|
|
37
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note G – Long-Term Debt(Continued)
Payments of the debt are scheduled as follows:
| | | | | | | | | | | | | | | |
| | Senior Notes
| | Convertible Subordinated Debentures
| | Revolving Credit Notes
| | Other Long-Term Debt
| | Total
|
2005 | | $ | — | | $ | — | | $ | — | | $ | 2,411 | | $ | 2,411 |
2006 | | | — | | | — | | | — | | | 2,318 | | | 2,318 |
2007 | | | — | | | 73,328 | | | — | | | 1,133 | | | 74,461 |
2008 | | | — | | | — | | | — | | | 1,069 | | | 1,069 |
2009 | | | — | | | — | | | — | | | 595 | | | 595 |
2010 | | | — | | | — | | | — | | | 552 | | | 552 |
Later years | | | 335,798 | | | — | | | — | | | 2,479 | | | 338,277 |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| | $ | 335,798 | | $ | 73,328 | | $ | — | | $ | 10,557 | | $ | 419,683 |
| |
|
| |
|
| |
|
| |
|
| |
|
|
On May 30, 2003, the Company completed a private issuance of $125 million principal amount of 7 3/4% Senior Notes (the “7 3/4% Notes”) due 2013 pursuant to Rule 144A under the Securities Act of 1933, and issued a redemption notice for all of the $125 million in 8 7/8% Senior Notes issued May 29, 1996 that were then outstanding. The financial covenants of the 7 3/4% Notes are substantially similar to those for the other existing Notes, including restrictions on certain payments. Concurrent with the completion of the 7 3/4% Note issuance, the Company entered into a derivative financial instrument to swap the entire $125 million notional amount to a floating interest rate equal to LIBOR plus 3.69%, set six months in arrears. The effective rate at March 31, 2004 was 4.85%.
On April 1, 1997, DIMON Incorporated issued $73,328 of 6 1/4% Convertible Subordinated Debentures due on March 31, 2007 (the “Debentures”), net of the cancellation of $50,000 in fiscal 1999 settlement of the Intabex litigation. The Debentures are convertible into approximately 2,549 shares of the Company’s Common Stock at a conversion price of $28.77 per share at any time prior to maturity. The Debentures are subordinated in right of payment to all existing and future senior indebtedness, as defined, of the Company, and do not have a cross-default provision. The Debentures are redeemable at the option of the Company under certain circumstances on or after April 1, 2000.
On October 30, 2001, the Company completed a private issuance of $200 million principal amount of 9 5/8% Senior Notes (the “9 5/8% Notes”) due 2011 pursuant to Rule 144A under the Securities Act of 1933. The financial covenants of the 9 5/8% Notes are substantially similar to those for the 7 3/4% Notes, including restrictions on certain payments. The proceeds from the 9 5/8% Notes were used to repay certain existing indebtedness of the Company, including all amounts drawn under the Company’s then-existing $250 million syndicated credit facility then existing.
Concurrent with the completion of the 9 5/8% Note issuance, the Company entered into a derivative financial instrument to swap the entire $200 million notional amount to a floating interest rate equal to LIBOR plus 4.11%, set six months in arrears. The effective rate at March 31, 2004 was 5.27%.
On October 27, 2003, the Company completed a new three-year $150 million syndicated bank credit facility with a group of seven banks. The credit facility is subject to certain commitment fees and covenants that, among other things, requires the Company to maintain minimum working capital and tangible net worth amounts, require specific liquidity and long-term solvency ratios, including certain borrowing base restrictions, and restrict acquisitions. The Company continuously monitors its compliance with these covenants. At December 31, 2003 the Company’s consolidated fixed charge coverage ratio was 1.14 to 1, which was below the required covenant hurdle of 1.20 to 1. The Company obtained, with unanimous approval from the lender banks, a waiver for the December 31, 2003 covenant together with an amendment resetting the required hurdle in future periods to 1.00 to 1 through the period ending September 29, 2004. At March 31, 2004, the Company’s consolidated fixed charge coverage ratio was 0.969 to 1, which was below the amended covenant hurdle of 1 to 1. The Company obtained a waiver from the lender banks for the March 31, 2004 covenant together with an amendment resetting the required hurdle in future periods to 0.75 to 1 through the period ending September 29, 2004; 0.90 to 1 for the period from September 30 to December 30, 2004; and 1.05 to 1 for the period from December 31, 2004 through March 30, 2005. Thereafter, the hurdle returns to its originally defined level of 1.25 to 1 for the remainder of the facility’s term.
38
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note G – Long-Term Debt(Continued)
The credit facility’s initial term expires on October 26, 2006, and, subject to approval by the lenders, may be extended. The rates of interest are based on the Company’s published credit rating and vary according to the type of loan requested by the Company. During the life of the agreement, the interest rate could be the prime rate or the LIBOR rate adjusted. The primary advance rate is the agent bank’s base lending rate, 4% at March 31, 2004. The Company pays a commitment fee of 1% per annum on any unused portion of the facility. The new facility replaced a $165 million facility.
At March 31, 2004, the Company was permitted to make restricted payments, including cash dividends on its Common Stock, of up to $30.0 million.
Other long-term debt consists of obligations of DIMON Incorporated and the tobacco operations in Brazil, Italy, Thailand and Macedonia, and is payable at interest rates varying from 2.50% to 14.67%.
Note H – Long-Term Leases
The Company has both capital and operating leases. The operating leases are for land, buildings, automobiles and other equipment; the capital leases are primarily for production machinery and equipment. The capitalized lease obligations are payable through 2010. Interest rates are imputed at 3.25% to 6.75%. Amortization is included in depreciation expense. Minimum future obligations and capitalized amounts are as follows:
| | | | | | | |
| | Capital Leases
| | | Operating Leases
|
2005 | | $ | 829 | | | $ | 5,823 |
2006 | | | 780 | | | | 5,136 |
2007 | | | 722 | | | | 2,231 |
2008 | | | 713 | | | | 1,665 |
2009 | | | 713 | | | | 1,506 |
Remaining | | | 1,596 | | | | 12,130 |
| |
|
|
| |
|
|
| | $ | 5,353 | | | $ | 28,491 |
Less amount representing interest and deposits | | | 1,051 | | | | |
| |
|
|
| | | |
Present value of net minimum lease payments | | $ | 4,302 | | | | |
Less current portion of obligations under capital leases | | | 565 | | | | |
| |
|
|
| | | |
Long-term obligations under capital leases | | $ | 3,737 | | | | |
| |
|
|
| | | |
Capitalized amounts: | | | | | | | |
Buildings | | $ | 81 | | | | |
Machinery and equipment, primarily vehicles | | | 5,295 | | | | |
Accumulated amortization | | | (1,520 | ) | | | |
| |
|
|
| | | |
| | $ | 3,856 | | | | |
| |
|
|
| | | |
Note I – Preferred Stock
The Board of Directors is authorized to issue shares of Preferred Stock in series with variations as to the number of shares in any series. The Board of Directors also is authorized to establish the rights and privileges of such shares issued, including dividend and voting rights. At March 31, 2004, no shares had been issued.
39
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note J – Stock Incentive Plan
In November 2003, Shareholders approved the DIMON Incorporated 2003 Incentive Plan (2003 Plan) which incorporated shares remaining for issuance under the DIMON Incorporated Omnibus Stock Incentive Plan (Prior Plan) and authorized the addition of 2,200 shares for the 2003 Plan. The 2003 Plan authorizes the issuance of up to a total of 2,385 shares of common stock. This amount is subject to increase for shares issued in the event of a stock dividend, stock split, subdivision or combination or other similar change in the capital structure of the Company, or any other event that, in the judgment of the Executive Compensation Committee (the “Committee”), necessitates adjustment of the maximum number of shares available. The 2003 Plan authorizes the issuance of various stock incentives to any employee of the Company or any subsidiary and any member of the Board that the Committee determines has contributed to the profits or growth of the Company or its affiliates, including nonqualified or incentive stock options, stock appreciation rights, shares of restricted stock, performance shares and incentive awards.
Stock options granted under the 2003 Plan allow for the purchase of common stock at prices determined at the time the option is granted by the Committee. Stock appreciation rights (SARs) may be granted under the 2003 Plan in relation to option grants or independently of option grants. SARs generally entitle the participant to receive in cash the excess of the fair market value of a share of common stock on the date of exercise over the value of the SAR at the date of grant. Restricted stock is common stock that is both nontransferable and forfeitable unless and until certain conditions are satisfied. The shares pay dividends and have ordinary voting rights but are forfeitable if employment or Board service terminates before vesting. Pursuant to the DIMON Deferred Compensation Plan, Board members and certain other employees may defer both option and restricted share awards. See also Note K to the “Notes to the Consolidate Financial Statements.” As of March 31, 2004, 17 restricted shares had been deferred by Board members. As of March 31, 2004, 402 shares of restricted stock had been awarded under the Incentive Plan and 345 shares were outstanding. Performance shares granted under the 2003 Plan are an award, stated with respect to a specified number of shares of common stock that entitles the holder to receive shares of common stock, cash or a combination of both. As of March 31, 2004, no performance shares had been awarded under the Incentive Plan. Incentive awards granted under the Incentive Plan allow for selected individuals to receive cash payments upon attainment of stated performance objectives determined by the Committee. No awards may be granted under the 2003 Plan, as amended, after December 31, 2013.
The outstanding options and SARs awarded under the Prior Plan become exercisable on various dates as originally determined for the grants. Under the 2003 Incentive Plan, the Committee will determine the dates that the options and SARs become exercisable.
Prior to the authorization of the 2003 Plan, the Company maintained the DIMON Incorporated Directors’ Stock Plan which replaced The Non-Employee Directors’ Stock Option Plan. As of March 31, 2004 options to purchase 60 shares had been granted of which 55 shares were outstanding under the Directors Plan and 24 shares had been granted and were outstanding under the Non-Employee Directors’ Stock Option Plan. There are no plans to make any further awards under these plans.
The Company accounts for the costs of SARs as compensation charges to the income statement with quarterly adjustments for market price fluctuations. All other options are treated as equivalent shares outstanding. There was a $307 credit to income in 2004, $270 charge to income in 2003 and $218 credit to income in 2002 arising from adjustments in fair market values of the SARs.
Certain potentially dilutive options outstanding at June 30, 2003 and 2002, were not included in the computation of earnings per diluted share because their exercise prices were greater than the average market price of the common shares during the period, and accordingly, their effect is antidilutive. These shares totaled 2,032 at a weighted-average exercise price of $14.41 per share for 2003; and 2,300 shares at a weighted-average exercise price of $15.08 per share in 2002. At March 31, 2004, all outstanding options were excluded from the computation of earnings per diluted share because the effect of their inclusion was antidilutive. These shares totaled 3,591 at a weighted-average exercise price of $10.19 per share.
40
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note J – Stock Incentive Plan(Continued)
Information with respect to options and SARs follows:
| | | | | | | | | | | | | | |
| | March 31, 2004
| | | June 30,
| |
| | | 2003
| | | 2002
| |
Options and SARs outstanding at beginning of year | | | 4,137 | | | | 3,716 | | | | 3,253 | |
Options and SARs granted | | | 625 | | | | 738 | | | | 670 | |
Options and SARs exercised | | | (267 | ) | | | (22 | ) | | | — | |
Options and SARs cancelled | | | (160 | ) | | | (295 | ) | | | (207 | ) |
| | | |
|
|
| |
|
|
| |
|
|
|
Options and SARs outstanding at end of year | | | 4,335 | | | | 4,137 | | | | 3,716 | |
| | | |
SARs included as outstanding at end of year | | | 744 | | | | 750 | | | | 637 | |
| | | |
|
|
| |
|
|
| |
|
|
|
Options available for future grants at end of year | | | 2,385 | | | | 853 | | | | 1,377 | |
| | | |
|
|
| |
|
|
| |
|
|
|
Options and SARs exercisable at end of year | | | 2,456 | | | | 2,221 | | | | 2,277 | |
| | | |
|
|
| |
|
|
| |
|
|
|
Option and SAR exercise prices per share: | | | | | | | | | | | | |
Date of grant | | (at lowest price) | | $ | 6.95 | | | $ | 6.25 | | | $ | 7.44 | |
| | (at highest price) | | | 6.95 | | | | 6.25 | | | | 7.44 | |
Exercised | | (at lowest price) | | | 2.81 | | | | 4.63 | | | | — | |
| | (at highest price) | | | 5.50 | | | | 4.63 | | | | — | |
Cancelled | | (at lowest price) | | | 6.25 | | | | 2.81 | | | | 2.81 | |
| | (at highest price) | | | 22.31 | | | | 22.31 | | | | 22.31 | |
Weighted average option exercise price information for 2004, 2003 and 2002 follows:
| | | | | | | | | |
| | March 31, 2004
| | June 30,
|
| | | 2003
| | 2002
|
Outstanding at beginning of year | | $ | 9.73 | | $ | 11.08 | | $ | 12.03 |
Granted during the year | | | 6.95 | | | 6.25 | | | 7.44 |
Exercised during the year | | | 3.27 | | | 4.63 | | | — |
Cancelled during the year | | | 15.50 | | | 18.79 | | | 14.29 |
Outstanding at end of year | | | 9.52 | | | 9.73 | | | 11.08 |
Exercisable at end of year | | | 11.56 | | | 13.35 | | | 14.93 |
41
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note J – Stock Incentive Plan(Continued)
Option and SARS groups outstanding at March 31, 2004 and related weighted average price and life information follows:
| | | | | | | | | |
Grant Date by Fiscal Year
| | Outstanding
| | Exercisable
| | Exercise Price
| | Remaining Life (Fiscal Years)
|
1995 | | 253 | | 253 | | $ | 13.97 | | — |
1996 | | 278 | | 278 | | | 16.97 | | 1 |
1997 | | 302 | | 302 | | | 18.18 | | 2 |
1998 | | 324 | | 324 | | | 22.33 | | 3 |
1999 | | 613 | | 613 | | | 7.94 | | 4 |
2000 | | 116 | | 116 | | | 4.63 | | 5 |
2001 | | 448 | | 448 | | | 2.88 | | 6 |
2002 | | 652 | | 45 | | | 7.44 | | 7 |
2003 | | 732 | | 50 | | | 6.25 | | 8 |
2004 | | 617 | | 27 | | | 6.95 | | 9 |
| |
| |
| | | | | |
| | 4,335 | | 2,456 | | | | | |
The weighted average fair value at date of grant for options and SARS granted during 2004 and 2003 was $2.63 and $1.97 per option, respectively. The fair value of options and SARS at date of grant was estimated using the Black-Scholes model with the following weighted average assumptions:
| | | | | | |
Black-Scholes Assumptions
| | 2004
| | | 2003
| |
Expected Life in Years | | 7 | | | 7 | |
Interest Rate | | 4.21 | % | | 4.04 | % |
Volatility | | 52.58 | % | | 55.01 | % |
Dividend Yield | | 4.32 | % | | 4.80 | % |
42
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note K – Income Taxes
The components of income (loss) before income taxes, equity in net income (loss) of investee companies, minority interests, discontinued operations and extraordinary item consisted of the following:
| | | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
| | | 2003
| | | 2002
| |
U.S. | | $ | (20,097 | ) | | $ | (39,848 | ) | | $ | (46,306 | ) |
Non-U.S. | | | (4,343 | ) | | | 75,164 | | | | 82,764 | |
| |
|
|
| |
|
|
| |
|
|
|
Total | | $ | (24,440 | ) | | $ | 35,316 | | | $ | 36,458 | |
| |
|
|
| |
|
|
| |
|
|
|
The details of the amount shown for income taxes in the Statements of Consolidated Income and Comprehensive Income follow:
| | | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
| | | 2003
| | | 2002
| |
Current | | | | | | | | | | | | |
Federal | | $ | (60 | ) | | $ | 1,165 | | | $ | 688 | |
State | | | — | | | | — | | | | — | |
Non-U.S. | | | 11,017 | | | | 23,593 | | | | 9,308 | |
| |
|
|
| |
|
|
| |
|
|
|
| | $ | 10,957 | | | $ | 24,758 | | | $ | 9,996 | |
| |
|
|
| |
|
|
| |
|
|
|
Deferred | | | | | | | | | | | | |
Federal | | $ | (13,107 | ) | | $ | (10,836 | ) | | $ | (579 | ) |
State | | | 3,211 | | | | (959 | ) | | | — | |
Non-U.S. | | | (1,650 | ) | | | (3,899 | ) | | | 495 | |
| |
|
|
| |
|
|
| |
|
|
|
| | $ | (11,546 | ) | | $ | (15,694 | ) | | $ | (84 | ) |
| |
|
|
| |
|
|
| |
|
|
|
Total | | $ | (589 | ) | | $ | 9,064 | | | $ | 9,912 | |
The reasons for the difference between income tax expense based on income (loss) before income taxes, equity in net income (loss) of investee companies, minority interests and extraordinary item and the amount computed by applying the U.S. statutory federal income tax rate to such income are as follows:
| | | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
| | | 2003
| | | 2002
| |
Tax expense (benefit) at U.S. statutory rate | | $ | (8,554 | ) | | $ | 12,361 | | | $ | 12,760 | |
Effect of non-U.S. income taxes | | | 470 | | | | 279 | | | | (11,042 | ) |
U.S. taxes on non-U.S. income, net of tax credits | | | 1,400 | | | | 4,520 | | | | 7,207 | |
Goodwill impairment | | | 1,904 | | | | — | | | | — | |
Expired tax credits | | | 3,000 | | | | — | | | | — | |
Permanent items | | | 1,191 | | | | (8,096 | ) | | | 987 | |
| |
|
|
| |
|
|
| |
|
|
|
Actual tax expense (benefit) | | $ | (589 | ) | | $ | 9,064 | | | $ | 9,912 | |
43
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note K – Income Taxes(Continued)
The deferred tax liabilities (assets) are comprised of the following:
| | | | | | | | |
| | March 31, 2004
| | | June 30, 2003
| |
Deferred tax liabilities: | | | | | | | | |
Non-U.S. taxes | | $ | 1,306 | | | $ | 3,109 | |
Unremitted earnings of non-U.S. subsidiaries | | | 1,400 | | | | — | |
Fixed assets | | | 9,524 | | | | 11,702 | |
| |
|
|
| |
|
|
|
Total deferred tax liabilities | | $ | 12,230 | | | $ | 14,811 | |
| | |
Deferred tax assets: | | | | | | | | |
Reserves and accruals | | $ | (7,373 | ) | | $ | (10,642 | ) |
Restructuring accruals | | | (4,439 | ) | | | (1,091 | ) |
Tax Credits | | | (4,639 | ) | | | (8,242 | ) |
Tax loss carryforwards | | | (36,111 | ) | | | (19,604 | ) |
Derivative transactions | | | (8,174 | ) | | | (10,848 | ) |
Postretirement and other benefits | | | (18,299 | ) | | | (15,516 | ) |
Other | | | (6,181 | ) | | | (4,757 | ) |
| |
|
|
| |
|
|
|
Gross deferred tax assets | | | (85,216 | ) | | | (70,700 | ) |
Valuation allowance | | | 20,997 | | | | 16,271 | |
| |
|
|
| |
|
|
|
Total deferred tax assets | | $ | (64,219 | ) | | $ | (54,429 | ) |
| |
|
|
| |
|
|
|
Net deferred tax asset | | $ | (51,989 | ) | | $ | (39,618 | ) |
| |
|
|
| |
|
|
|
The following table presents the breakdown between current and non-current (assets) liabilities:
| | | | | | | | |
| | 2004
| | | 2003
| |
Current asset | | $ | (8,510 | ) | | $ | (8,875 | ) |
Non current asset | | | (48,390 | ) | | | (34,680 | ) |
Non current liability | | | 4,911 | | | | 3,937 | |
| |
|
|
| |
|
|
|
Net deferred tax asset | | $ | (51,989 | ) | | $ | (39,618 | ) |
| |
|
|
| |
|
|
|
The current portion of the deferred tax asset is included in “current deferred and recoverable income taxes” and the non-current asset is included in “deferred taxes and other deferred charges.”
For the nine months ended March 31, 2004, the valuation allowance increased by $4,726 due primarily to additional tax loss carryovers and management’s judgment as to realization of certain deferred tax assets. For the year ended June 30, 2003, the valuation allowance decreased by $14,192 due primarily to utilization of foreign tax credit carryovers in the U.S. At March 31, 2004 the Company has non-U.S. tax loss carryovers of $38,294 and U.S. federal and state tax loss carryovers of $52,250 and $156,918, respectively, that expire in 2005 and thereafter. Valuation allowances of $20,997 and $16,271 remain at March 31, 2004 and June 30, 2003, respectively, primarily related to state and non-U.S. tax loss carryovers and foreign tax credits that begin expiring in 2004.
Realization of deferred tax assets is dependent on generating sufficient taxable income prior to expiration of the loss carryovers. Although realization is not assured, management believes it is more likely than not that all of the deferred tax assets, net of applicable valuation allowances, will be realized. The amount of the deferred tax assets considered realizable could be reduced or increased if estimates of future taxable income change during the carryover period.
44
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note K – Income Taxes(Continued)
The Company has provided deferred income taxes of $1,400 for the estimated U.S. income taxes, net of foreign tax credits, pursuant to its plans to remit certain undistributed earnings from foreign subsidiaries. No provision has been made for U.S. or foreign taxes that may result from future remittances of approximately $141,000 of undistributed earnings of foreign subsidiaries because management expects that such earnings will be reinvested overseas indefinitely. Determination of the amount of any unrecognized deferred income tax liability on these unremitted earnings is not practicable.
Note L – Employee Benefits
Retirement Benefits
The Company has a Cash Balance Plan that provides retirement benefits for substantially all U.S. salaried personnel based on years of service rendered, age and compensation. The Company also maintains various other Excess Benefit and Supplemental Plans that provide additional benefits to (1) certain individuals whose compensation and the resulting benefits that would have actually been paid are limited by regulations imposed by the Internal Revenue Code and (2) certain individuals in key positions. The Company funds these plans in amounts consistent with the funding requirements of Federal Law and Regulations.
Additional non-U.S. plans sponsored by certain subsidiaries cover substantially all of the full-time employees located in Germany, Greece and Turkey.
A reconciliation of benefit obligations, plan assets and funded status of the plans at March 31, 2004 and June 30, 2003, the measurement dates, was as follows:
| | | | | | | | |
| | March 31, 2004
| | | June 30, 2003
| |
Change in Benefit Obligation | | | | | | | | |
Benefit obligation, beginning | | $ | 67,467 | | | $ | 59,374 | |
Service cost | | | 2,357 | | | | 2,408 | |
Interest cost | | | 3,245 | | | | 4,228 | |
Actuarial loss | | | 2,017 | | | | 6,881 | |
Amendments and curtailments | | | 345 | | | | 78 | |
Benefits paid | | | (3,752 | ) | | | (5,502 | ) |
| |
|
|
| |
|
|
|
Benefit obligation, ending | | $ | 71,679 | | | $ | 67,467 | |
| |
|
|
| |
|
|
|
Change in Plan Assets | | | | | | | | |
Fair value of plan assets, beginning | | $ | 33,140 | | | $ | 35,951 | |
Actual return on plan assets | | | 2,209 | | | | 967 | |
Company contribution | | | 2,279 | | | | 1,724 | |
Benefits paid | | | (3,855 | ) | | | (5,502 | ) |
| |
|
|
| |
|
|
|
Fair value of plan assets, ending | | $ | 33,773 | | | $ | 33,140 | |
| |
|
|
| |
|
|
|
Funded status of plan | | $ | (37,906 | ) | | $ | (34,327 | ) |
Unrecognized actuarial loss | | | 10,162 | | | | 9,524 | |
Unrecognized prior service cost | | | 2,722 | | | | 2,448 | |
| |
|
|
| |
|
|
|
Net amount recognized | | $ | (25,022 | ) | | $ | (22,355 | ) |
| |
|
|
| |
|
|
|
45
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note L– Employee Benefits(Continued)
Retirement Benefits (Continued)
| | | | | | | | |
| | March 31, 2004
| | | June 30, 2003
| |
Amounts Recognized in the Consolidated Balance Sheet Consist of: | | | | | | | | |
Prepaid benefit cost | | $ | — | | | $ | — | |
Accrued benefit liability | | | (33,400 | ) | | | (29,416 | ) |
Intangible asset | | | 1,934 | | | | 1,946 | |
Accumulated other comprehensive income | | | 6,444 | | | | 5,115 | |
| |
|
|
| |
|
|
|
Net amount recognized | | $ | (25,022 | ) | | $ | (22,355 | ) |
The accumulated benefit obligation for all defined benefit pension plans was $66,452 at March 31, 2004 and $62,905 at June 30, 2003.
| | | | | | |
| | March 31, 2004
| | June 30, 2003
|
Information for Pension Plans with Accumulated Benefit | | | | | | |
Obligation in Excess of Plan Assets: | | | | | | |
Projected benefit obligation | | $ | 71,679 | | $ | 67,467 |
Accumulated benefit obligation | | | 66,452 | | | 62,905 |
Fair value of plan assets | | | 33,773 | | | 33,140 |
Net periodic pension costs included the following components:
| | | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
| | | 2003
| | | 2002
| |
Service cost | | $ | 2,357 | | | $ | 2,408 | | | $ | 1,861 | |
Interest expense | | | 3,245 | | | | 4,228 | | | | 4,186 | |
Expected return on plan assets | | | (1,891 | ) | | | (3,039 | ) | | | (3,625 | ) |
Amortization of prior service cost | | | 251 | | | | 291 | | | | 262 | |
Amortization of transition amount | | | — | | | | (252 | ) | | | (348 | ) |
Actuarial loss (gain) | | | 767 | | | | 291 | | | | (224 | ) |
| |
|
|
| |
|
|
| |
|
|
|
Net periodic pension cost | | $ | 4,729 | | | $ | 3,927 | | | $ | 2,112 | |
| | | | | | |
| | March 31, 2004
| | June 30, 2003
|
Additional Information: | | | | | | |
Increase in minimum liability included in other comprehensive income | | $ | 6,444 | | $ | 5,115 |
For the U.S. plans, benefit obligations and net periodic pension costs for the Retirement Plan and the Excess Benefit and Supplemental Plans were determined using assumed discount rates of 6.00% for 2004 and 2003 and 7.25% for 2002. Assumed compensation increases were 4.0% for 2004, 3.5% for 2003 and 4.0% for 2002 for the Retirement Plan and for the Excess Benefit Plan. The assumed long-term rate of return on plan assets was 8.5% for 2004, 8.0% for 2003 and 9.0% for 2002 for the Retirement Plan. The expected long-term rate of return on assets was determined based upon historical investment performance, current asset allocation and estimates of future investment performance by asset class. For non-U.S. plans, discount rates and assumed compensation increases are in accordance with locally accepted practice. No assumed long-term rate of return is made for non-U.S. plan assets as these plans are generally not funded.
46
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA(Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note L – Employee Benefits (Continued)
Plan Assets
The Company’s pension plan weighted-average asset allocations at March 31, 2004 and June 30, 2003 by asset category are as follows:
| | | | | | |
| | March 31, 2004
| | | June 30, 2003
| |
Asset Category: | | | | | | |
Equity securities | | 39 | % | | 48 | % |
Fixed income | | 18 | % | | 46 | % |
Other short term investments | | 43 | % | | 6 | % |
| |
|
| |
|
|
Total | | 100 | % | | 100 | % |
The Company’s investment objectives are to generate consistent total investment return to pay anticipated plan benefits, while minimizing long-term costs. Financial objectives underlying this policy include maintaining plan contributions at a reasonable level relative to benefits provided and assuring that unfunded obligations do not grow to a level to adversely affect the Company’s financial health. The Company’s target asset allocation strategy is a 60%/40% allocation between equity and fixed income securities. As of March 31, 2004, based upon the recommendation of the Company’s Investment Advisor and the Investment Committee, new investment managers had been selected. The asset allocation at March 31, 2004 does not reflect the eventual investment allocation after all funds were transferred and invested by the new investment managers in April 2004. Manager performance is measured against investment objectives and objective benchmarks, including: Salomon 90 Day Treasury Bill, Lehman Brothers Intermediate Govt; Credit, Lehman Aggregate Index, Russell 1000 Value, Russell 1000 Growth, Russell 2500 Value, Russell 2000 Growth, and MSCI EAFE. The Portfolio Objective is to exceed the actuarial return on assets assumption. Management regularly reviews portfolio allocations and periodically rebalances the portfolio to the targeted allocations when considered appropriate. Equity securities do not include the Company’s common stock.
Cash Flows
Contributions
The Company expects to contribute $550 to its pension plan in 2005.
Estimated Future Benefit Payments
The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid:
| | | | | | |
| | Pension Benefits
| | Other Benefits
|
2005 | | $ | 4,552 | | $ | 2,212 |
2006 | | | 4,485 | | | 2,140 |
2007 | | | 5,158 | | | 2,080 |
2008 | | | 5,341 | | | 2,030 |
2009 | | | 4,867 | | | 1,964 |
Years 2010-2014 | | | 30,437 | | | 9,413 |
The Company also sponsors a 401-k savings plan for most of its salaried employees located in the United States. The Company’s contributions to the plan were $295 in 2004, $401 in 2003 and $396 in 2002.
The DIMON Compensation Deferral Plan was approved by the Board on June 23, 2003. The plan is available to certain employees and non-employee members of the Board. Eligible participants may elect to defer specified portions of cash or equity based compensation received and have the deferred amount treated as if invested in specified investment vehicles. The Compensation Deferral Plan is unfunded with a payable of $165 at March 31, 2004. Withdrawals from the Plan are not permitted until the termination of a participant’s service. See also Note J to the “Notes to Consolidated Financial Statements” for further information regarding equity based compensation.
47
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note L – Employee Benefits(Continued)
Postretirement Health and Life Insurance Benefits
The Company provides certain health and life insurance benefits to retired U.S. employees (and their eligible dependents) who meet specified age and service requirements. Plan assets consist of paid-up life insurance policies on certain current retirees. The Company retains the right, subject to existing agreements, to modify or eliminate the medical benefits.
A reconciliation of benefit obligations, plan assets and funded status of the plans was as follows:
| | | | | | | | |
| | March 31, 2004
| | | June 30, 2003
| |
Change in Benefit Obligation | | | | | | | | |
Benefit obligation, beginning | | $ | 22,048 | | | $ | 14,503 | |
Service cost | | | 335 | | | | 342 | |
Interest cost | | | 1,005 | | | | 1,357 | |
Actuarial loss | | | 1,068 | | | | 7,924 | |
Benefits paid | | | (1,409 | ) | | | (2,078 | ) |
| |
|
|
| |
|
|
|
Benefit obligation, ending | | $ | 23,047 | | | $ | 22,048 | |
| |
|
|
| |
|
|
|
Change in Plan Assets | | | | | | | | |
Fair value of plan assets, beginning | | $ | 154 | | | $ | 95 | |
Actual return on plan assets | | | (29 | ) | | | (8 | ) |
Company contribution | | | 153 | | | | 185 | |
Benefits paid | | | (233 | ) | | | (118 | ) |
| |
|
|
| |
|
|
|
Fair value of plan assets, ending | | $ | 45 | | | $ | 154 | |
| |
|
|
| |
|
|
|
Funded status of plan | | $ | (23,002 | ) | | $ | (21,894 | ) |
Unrecognized actuarial loss | | | 8,793 | | | | 8,004 | |
Unrecognized prior service cost | | | (2,001 | ) | | | (2,232 | ) |
| |
|
|
| |
|
|
|
Net amount recognized | | $ | (16,210 | ) | | $ | (16,122 | ) |
| |
|
|
| |
|
|
|
Amounts Recognized in the Consolidated Balance Sheet Consist of: | | | | | | | | |
Prepaid benefit cost | | $ | — | | | $ | — | |
Accrued benefit liability | | | (16,210 | ) | | | (16,122 | ) |
Intangible asset | | | — | | | | — | |
Accumulated other comprehensive income | | | — | | | | — | |
| |
|
|
| |
|
|
|
Net amount recognized | | $ | (16,210 | ) | | $ | (16,122 | ) |
For measurement purposes, a 10.0% annual rate of increase in the per capita cost of covered health care benefits was assumed for 2004 and 2003. The rate was assumed to decrease gradually to 5.0% by the year 2011 in 2004 and 2010 in 2003. Benefit obligations and net periodic pension costs were determined using assumed discount rates of 6.00% for 2004 and 2003 and 7.25% for 2002. Assumed compensation increases were 4.0% for 2004, 3.5% for 2003 and 4.0% for 2002. The assumed long-term rate of return on plan assets was 4.75% for 2004, 5.5% for 2003 and 2002. The expected long-term rate of return on assets was determined based upon historical investment performance, current asset allocation and estimates of future investment performance by asset class.
48
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note L – Employee Benefits(Continued)
Postretirement Health and Life Insurance Benefits (Continued)
Plan Assets
The Company’s pension plan weighted-average asset allocations at March 31, 2004 and June 30, 2003 by asset category are as follows:
| | | | | | |
| | March 31, 2004
| | | June 30, 2003
| |
Asset Category: | | | | | | |
Fixed Income | | 100 | % | | 100 | % |
The Company’s investment objectives are to generate consistent total investment return to pay anticipated plan benefits, while minimizing long-term costs. Financial objectives underlying this policy include maintaining plan contributions at a reasonable level relative to benefits provided and assuring that unfunded obligations do not grow to a level to adversely affect the Company’s financial health. The Company’s target asset allocation strategy for postretirement benefits is a 100% allocation in fixed income securities.
Net periodic benefit costs included the following components:
| | | | | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | | Years Ended June 30,
| |
| | | 2003
| | | 2002
| |
Service cost | | $ | 335 | | | $ | 342 | | | $ | 199 | |
Interest expense | | | 1,005 | | | | 1,357 | | | | 1,004 | |
Expected return on plan assets | | | (6 | ) | | | (5 | ) | | | (10 | ) |
Amortization of prior service cost | | | (231 | ) | | | (308 | ) | | | (308 | ) |
Actuarial (gain)/loss | | | 314 | | | | 194 | | | | (33 | ) |
| |
|
|
| |
|
|
| |
|
|
|
Net pension cost | | $ | 1,417 | | | $ | 1,580 | | | $ | 852 | |
| |
|
|
| |
|
|
| |
|
|
|
Assumed health care cost trend rates have a significant effect on the amounts reported for the health care plans. A one-percentage-point change in assumed health care cost trend rates would have the following effects:
| | | | | | | |
| | 1-Percentage- Point Increase
| | 1-Percentage- Point Decrease
| |
Effect on total of service and interest cost components | | $ | 120 | | $ | (104 | ) |
Effect on postretirement benefit obligation | | | 1,130 | | | (1,004 | ) |
The Company continues to evaluate ways to better manage these benefits and control the costs. Any changes in the plan or revisions to assumptions that affect the amount of expected future benefits may have a significant effect on the amount of the reported obligation and annual expense. The Company expects to contribute $300 to its postretirement benefit plan in 2005.
Employees in operations located in certain foreign countries are covered by various foreign postretirement life insurance benefit arrangements. There are no postretirement health benefits due to coverage ceasing at retirement or coverage continuing through a national health system. For these foreign plans, the cost of benefits charged to income was not material in 2004, 2003 and 2002.
Note M – Segment Information
The Company operates in one segment, the tobacco business: purchasing, processing, selling and storing leaf tobacco. The Company purchases tobacco in more than 40 countries and ships tobacco to approximately 90 countries.
Geographic information as to sales and other operating revenues is based on the destination of the product sold. Long-lived assets are classified based on the location of the asset.
49
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note M – Segment Information(Continued)
| | | | | | | | | |
| | Nine Months Ended March 31, 2004
| | Years Ended June 30,
|
| | | 2003
| | 2002
|
Sales and Other Operating Revenues: | | | | | | | | | |
United States | | $ | 181,345 | | $ | 239,207 | | $ | 248,620 |
Germany | | | 100,980 | | | 175,700 | | | 186,480 |
Japan | | | 67,043 | | | 133,418 | | | 133,861 |
Other | | | 452,715 | | | 649,142 | | | 623,652 |
| |
|
| |
|
| |
|
|
| | $ | 802,083 | | $ | 1,197,467 | | $ | 1,192,613 |
| |
|
| |
|
| |
|
|
Sales and Other Operating Revenues to Major Customers: | | | | | | | | | |
Of the 2004, 2003 and 2002 sales and other operating revenues, approximately 35%, 39% and 36%, respectively, were to various tobacco companies which management has reason to believe are now owned by or under the common control of two companies. (The following table summarizes the net sales to each customer for the periods indicated: ) | | | | | | | | | |
| | | |
Customer A | | $ | 148,456 | | $ | 214,802 | | $ | 165,092 |
Customer B | | | 133,145 | | | 256,377 | | | 264,037 |
| |
|
| |
|
| |
|
|
| | $ | 281,601 | | $ | 471,179 | | $ | 429,129 |
| |
|
| |
|
| |
|
|
| | | |
Long-Lived Assets: | | | | | | | | | |
United States | | $ | 23,543 | | $ | 37,503 | | $ | 44,599 |
Brazil | | | 45,592 | | | 40,262 | | | 38,979 |
Malawi | | | 24,208 | | | 25,566 | | | 28,107 |
Tanzania | | | 21,663 | | | 22,582 | | | 24,470 |
Zimbabwe | | | 39,685 | | | 46,292 | | | 49,418 |
South America | | | 1,835 | | | 1,769 | | | 1,970 |
Europe | | | 49,776 | | | 43,381 | | | 34,910 |
Asia | | | 6,695 | | | 7,043 | | | 7,306 |
Other | | | 25,158 | | | 19,785 | | | 19,630 |
| |
|
| |
|
| |
|
|
Long-Lived Assets | | $ | 238,155 | | $ | 244,183 | | $ | 249,389 |
Note N – Shareholder Rights Plan
Pursuant to a Rights Agreement, dated as of March 31, 1995, between the Company and First Union National Bank of North Carolina, as Rights Agent, one right to purchase common stock is attached to each share of DIMON common stock. Each right entitles the holder thereof to purchase from the Company one share of common stock at a price of $65.00 per share only after the date on which any person or group of affiliated persons acquires additional shares of common stock representing 10% or more of the outstanding common stock (a “Triggering Event”). After a Triggering Event, each holder of a right will have the right to receive common stock (or, in certain circumstances, cash, property or other securities of the Company) having a value equal to two times the exercise price of the right, and all rights that are beneficially owned by such acquiring person (or certain related parties) will be null and void. If the Company is acquired in a merger or other business combination, each right will entitle the holder, other than the acquiring person, to purchase securities of the surviving company having a market value equal to twice the exercise price of the rights. Following the acquisition by any person of more than the threshold percentage of the Company’s outstanding common stock but less than 50% of such stock, the Company may exchange one share of common stock for each right (other than rights held by such acquiring person). Until the rights become exercisable, they may be redeemed by the Company at a price of one cent per right. The rights expire on March 31, 2005.
50
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note O – Contingencies and Other Information
In 1993 and 1996, the Company received notices from Brazilian tax authorities of proposed adjustments to the income tax returns of the Company’s entities located in Brazil for the calendar years ending 1988 through 1992. The Company has successfully defeated many of the proposed adjustments in litigation and settled the other issues under REFIS and Tax Amnesty programs. As of March 31, 2004, total tax, penalties and interest relating to still unresolved issues is approximately $1.4 million.
On October 31, 2002, the Company received an assessment from the tax authorities in Germany regarding the taxable gain from the sale of its flower operations, Florimex, in September 1998. The report concluded the values of the real estate located in Germany were greater than those arrived at with the buyer of the flower operation. The proposed adjustment to income tax, including interest, is equivalent to approximately $5.1 million for federal corporate income tax and $2.9 million for local trade income tax. The Company has challenged this finding with valuations that support the values used in the original filings and is currently discussing the issue with the tax officials in Germany.
In September 2002 and in January 2004, the Company’s Tanzanian operation received assessments for income taxes equivalent to approximately $1.0 million and $5.3 million, respectively. The Company has filed protests and appeals and is currently awaiting replies.
The Company believes it has properly reported its income and paid its taxes in Brazil, Germany and Tanzania in accordance with applicable laws and intends to vigorously contest the proposed adjustments. The Company expects the ultimate resolution of these matters will not have a material adverse effect on the Company’s consolidated balance sheet or results of operations.
In October 2001, the Directorate General for Competition (DGCOMP) of the European Commission (EC) began conducting an administrative investigation into certain tobacco buying and selling practices alleged to have occurred within the leaf tobacco industry in Spain and Italy. The Company believes that the DGCOMP may be conducting similar investigations in other countries. Its subsidiaries in Spain (Agroexpansion) and Italy (DIMON Italia) are cooperating with the DGCOMP. Based on its understanding of the facts pertaining to the activities of Spanish and Italian tobacco processors, including Agroexpansion and DIMON Italia, respectively, the Company believes there have been infringements of EU law. Agroexpansion and DIMON Italia believe that there are mitigating circumstances in the structure and traditional operation of tobacco production and processing in these markets. In December 2003 and February 2004, the EC issued Statements of Objections (“the Statements”) relating to buying practices in Spain and Italy, respectively. The Statements allege that the buying practices of the tobacco processors and producers in Spain and Italy constitute infringements of EU competition laws. The Statements indicated that the EC intends to assess administrative penalties, but did not provide any indication as to what those penalties may be. Both Agroexpansion and DIMON Italia have filed a response to the Statements of Objections relating to Spain and Italy, respectively. The EU conducted an oral hearing on the Spanish matter in March 2004 and has scheduled an oral hearing of the Italian matter during June. Although it is impossible to assess the amount of any penalties at this time, they could be material to the Company’s earnings. The Company believes that the cooperation of its subsidiaries with the DGCOMP during its investigations could result in a reduction of the amount of any penalties that otherwise could be imposed.
In September 2002, the Argentina National Commission for Defense of Competition (“NCDC”) began an administrative inquiry into the tobacco and cigarette industry in Argentina. The Company’s subsidiary in Argentina, DIMON Argentina S.A., is cooperating with the NCDC. The Company cannot predict whether the inquiry will result in any further action by the NCDC.
The Company recently discovered potential irregularities with respect to certain bank accounts in two countries in southern Europe and central Asia. The Audit Committee of the Company’s Board of Directors engaged an outside law firm to conduct an investigation of activity relating to these accounts. That investigation revealed that, although the amounts involved were not material and had no material impact on the Company’s historical financial statements, there have been payments from these accounts that may have violated the U.S. Foreign Corrupt Practices Act. The Company voluntarily reported the payments to the appropriate U.S. authorities. The Company has closed the accounts in question and is implementing personnel changes and other measures designed to prevent similar situations in the future, including the addition of new finance and internal audit staff in Europe and enhancement of existing training programs.
51
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note O – Contingencies and Other Information(Continued)
If the U.S. authorities determine that there have been violations of the Foreign Corrupt Practices Act, they may seek to impose sanctions on the Company that may include injunctive relief, disgorgement, fines, penalties and modifications to business practices. It is not possible to predict at this time whether the authorities will determine that violations have occurred, and if they do, what sanctions they might seek to impose. It is also not possible to predict how the government’s investigation or any resulting sanctions may impact the Company’s business, results of operations or financial performance, although any monetary penalty assessed may be material to its results of operations in the quarter in which it is imposed. The Company will continue to cooperate with the authorities in these matters.
The Company and certain of its foreign subsidiaries guarantee bank loans to growers to finance their crop. Under longer-term arrangements, the Company may also guarantee financing on growers’ construction of curing barns or other tobacco production assets. The Company also guarantees bank loans to certain tobacco cooperatives to assist with the financing of their growers’ crops. Guaranteed loans are generally repaid concurrent with the delivery of tobacco to the Company. The Company is obligated to repay any guaranteed loan should the grower or tobacco cooperative default. If default occurs, the Company has recourse against the grower or cooperative. At March 31, 2004, the Company is guarantor of an amount not to exceed $158.1 million with $142.3 million outstanding under these guarantees. The majority of the current outstanding guarantees expire within the respective annual crop cycle. The Company considers the risk of significant loss under these guarantees and other contingencies to be remote, and the accrual recorded for exposure under them was not material at March 31, 2004.
On August 21, 2001, the Company’s subsidiary in Brazil won a claim related to certain excise taxes (“IPI credit bonus”) for the years 1983 through 1990 and is now pursuing collection. The collection procedures are not clear and the total realization process could potentially be over many years. The Company is unable to estimate the realizable value of this claim as of March 31, 2004.
Zimbabwe remains in a period of civil unrest in combination with a deteriorating economy. Should the current political situation continue, the Company could experience disruptions and delays associated with its Zimbabwe operations. If the political situation in Zimbabwe continues to deteriorate, the Company’s ability to recover its assets there could be impaired. The Company’s Zimbabwe subsidiary has long-lived assets of approximately $39.7 million as of March 31, 2004.
Note P – Extraordinary Item
On May 1, 2003, the Company received $2,734 from the United Nations Compensation Commission in connection with a claim filed by a predecessor company, Monk-Austin, Incorporated. The claim arose from an uncollected trade receivable from the Iraqi Tobacco Monopoly, which related to transactions that occurred prior to Iraq’s invasion of Kuwait in August 1990. The predecessor company charged off the entire receivable, net of tax, as a $5,202 extraordinary loss during its fiscal year 1991. The extraordinary gain of $1,777 is recorded net of tax of $957.
52
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note Q – Selected Quarterly Financial Data (Unaudited)
| | | | | | | | | | | | | | | | |
| | First Quarter
| | | Second Quarter
| | | Third Quarter
| | | Fiscal Year
| |
Nine Months Ended March 31, 2004 | | | | | | | | | | | | | | | | |
Sales and Other Operating Revenue | | $ | 214,416 | | | $ | 284,552 | | | $ | 303,115 | | | $ | 802,083 | |
Gross Profit | | | 41,681 | | | | 30,135 | | | | 33,640 | | | | 105,456 | |
Income (loss) from continuing operations | | | 5,709 | | | | (2,681 | ) | | | (24,567 | ) | | | (21,539 | ) |
Loss from discontinued operations | | | (240 | ) | | | (338 | ) | | | (10,751 | ) | | | (11,329 | ) |
Net Income (Loss) (1) | | | 5,469 | | | | (3,019 | ) | | | (35,318 | ) | | | (32,868 | ) |
Per Share of Common Stock: | | | | | | | | | | | | | | | | |
Basic Earnings (Loss) (2) | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations | | | .13 | | | | (.06 | ) | | | (.55 | ) | | | (.48 | ) |
Loss from discontinued operations | | | (.01 | ) | | | (.01 | ) | | | (.24 | ) | | | (.25 | ) |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Net income (loss) | | | .12 | | | | (.07 | ) | | | (.79 | ) | | | (.73 | ) |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Diluted Earnings (Loss) (2) | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations | | | .13 | | | | (.06 | ) | | | (.55 | ) | | | (.48 | ) |
Loss from discontinued operations | | | (.01 | ) | | | (.01 | ) | | | (.24 | ) | | | (.25 | ) |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Net income (loss) | | | .12 | * | | | (.07 | )* | | | (.79 | )* | | | (.73 | )* |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Cash Dividends per Share | | | .075 | | | | .075 | | | | .075 | | | | .225 | |
Market Price - High | | | 7.46 | | | | 7.60 | | | | 7.25 | | | | 7.60 | |
- Low | | | 6.53 | | | | 6.40 | | | | 6.28 | | | | 6.28 | |
| | | | | | | | | | | | | | | | | | | | |
| | First Quarter
| �� | | Second Quarter
| | | Third Quarter
| | | Fourth Quarter
| | | Fiscal Year
| |
Year Ended June 30, 2003 | | | | | | | | | | | | | | | | | | | | |
Sales and Other Operating Revenue | | $ | 253,746 | | | $ | 299,145 | | | $ | 296,356 | | | $ | 348,220 | | | $ | 1,197,467 | |
Gross Profit | | | 54,287 | | | | 42,919 | | | | 39,520 | | | | 68,559 | | | | 205,285 | |
Income from continuing operations (3) | | | 5,077 | | | | 6,278 | | | | 2,520 | | | | 12,954 | | | | 26,829 | |
Income (loss) from discontinued operations | | | (19 | ) | | | (6 | ) | | | 150 | | | | (674 | ) | | | (549 | ) |
Extraordinary item | | | — | | | | — | | | | — | | | | 1,777 | | | | 1,777 | |
Net income | | | 5,058 | | | | 6,272 | | | | 2,670 | | | | 14,057 | | | | 28,057 | |
Per Share of Common Stock: | | | | | | | | | | | | | | | | | | | | |
Basic Earnings | | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations | | | .11 | | | | .14 | | | | .06 | | | | .29 | | | | .60 | |
Income (loss) from discontinued operations | | | — | | | | — | | | | — | | | | (.01 | ) | | | (.01 | ) |
Extraordinary item: Iraqi receivable recovery | | | — | | | | — | | | | — | | | | .04 | | | | .04 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Net income | | | .11 | | | | .14 | | | | .06 | | | | .32 | | | | .63 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Diluted Earnings | | | | | | | | | | | | | | | | | | | | |
Income from continuing operations | | | .11 | | | | .14 | | | | .06 | | | | .28 | | | | .59 | |
Income (loss) from discontinued operations | | | — | | | | — | | | | — | | | | (.01 | ) | | | (.01 | ) |
Extraordinary item: Iraqi receivable recovery | | | — | | | | — | | | | — | | | | .04 | | | | .04 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Net income | | | .11 | * | | | .14 | * | | | .06 | * | | | .31 | | | | .62 | * |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Cash Dividends per Share | | | .05 | | | | .075 | | | | .075 | | | | .075 | | | | .275 | |
Market Price -High | | | 7.00 | | | | 6.60 | | | | 7.50 | | | | 7.44 | | | | 7.50 | |
- Low | | | 5.45 | | | | 5.35 | | | | 5.60 | | | | 5.69 | | | | 5.35 | |
53
ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA(Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
DIMON Incorporated and Subsidiaries
(in thousands)
Note Q – Selected Quarterly Financial Data (Unaudited)(Continued)
(1) | Third quarter of fiscal 04 includes $29,480 in restructuring and asset impairment charges of which $6,941 has been reclassified as discontinued operations. |
(2) | Does not add due to rounding. |
(3) | Fourth quarter of fiscal 2003 includes $6,000 for litigation settlement. |
* | Assumed conversion of Convertible Debentures at the beginning of each period has an antidilutive effect on earnings (loss) per share. For the second and third quarters ended December 31, 2003 and March 31, 2004, respectively, and the nine month transitional year ended March 31, 2004, all outstanding restricted stock and stock options are excluded because their inclusion would have an antidilutive effect on the loss per share. |
54
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of DIMON Incorporated
We have audited the accompanying consolidated balance sheets of DIMON Incorporated and subsidiaries as of March 31, 2004 and June 30, 2003, and the related consolidated statements of income and comprehensive income, stockholders’ equity and cash flows for the nine month period ended March 31, 2004 and for each of the two years in the period ended June 30, 2003. Our audits also included the financial statement schedule listed in the Index at Item 15(a). These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of DIMON Incorporated and subsidiaries at March 31, 2004 and June 30, 2003, and the consolidated results of their operations and their cash flows for the nine month period ended March 31, 2004 and each of the two years in the period ended June 30, 2003, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
As discussed in Note A to the consolidated financial statements, in 2003 the Company adopted Statement of Financial Accounting Standards No. 142,Goodwill and Intangible Assets.
|
/s/ Ernst & Young LLP |
Greensboro, North Carolina |
May 27, 2004, |
except for Note G, as to which the date is |
June 9, 2004 |
and Note B, as to which the date is |
September 30, 2004 |
55